{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T21:19:11Z","timestamp":1788643151731,"version":"build-2803163510"},"reference-count":391,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371271, U2002220"],"award-info":[{"award-number":["82371271, U2002220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the innovation team of stress and disorder in nervous system in Yunnan Province","award":["202305AS350011"],"award-info":[{"award-number":["202305AS350011"]}]},{"name":"Yunling Scholar","award":["1097821401"],"award-info":[{"award-number":["1097821401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00018-024-05402-0","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T09:02:22Z","timestamp":1723885342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differentiation and regulation of CD4+ T cell subsets in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"81","author":[{"given":"Xiaowei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-3159","authenticated-orcid":false,"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"issue":"1","key":"5402_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER (2022) Preventing Parkinson\u2019s disease: an environmental agenda. J Parkinsons Dis 12(1):45\u201368. https:\/\/doi.org\/10.3233\/JPD-212922","journal-title":"J Parkinsons Dis"},{"key":"5402_CR2","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"5402_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-023-00410-1","author":"KR Chaudhuri","year":"2024","unstructured":"Chaudhuri KR, Azulay JP, Odin P, Lindvall S, Domingos J, Alobaidi A et al (2024) Economic Burden of Parkinson\u2019s Disease: a multinational, Real-World, cost-of-illness study. Drugs Real World Outcomes. https:\/\/doi.org\/10.1007\/s40801-023-00410-1","journal-title":"Drugs Real World Outcomes"},{"issue":"4","key":"5402_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.18553\/jmcp.2022.28.4.405","volume":"28","author":"H Albarmawi","year":"2022","unstructured":"Albarmawi H, Zhou S, Shulman LM, Gandhi AB, Johnson A, Myers DE et al (2022) The economic burden of Parkinson disease among Medicare beneficiaries. J Manag Care Spec Pharm 28(4):405\u2013414. https:\/\/doi.org\/10.18553\/jmcp.2022.28.4.405","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"5402_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cns.13549","volume":"27","author":"N Zhao","year":"2021","unstructured":"Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS et al (2021) Quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27(3):270\u2013279. https:\/\/doi.org\/10.1111\/cns.13549","journal-title":"CNS Neurosci Ther"},{"key":"5402_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and Pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol 18:95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Pathol"},{"issue":"21","key":"5402_CR7","doi-asserted-by":"publisher","first-page":"e2058","DOI":"10.1212\/WNL.0000000000207871","volume":"101","author":"B Krzyzanowski","year":"2023","unstructured":"Krzyzanowski B, Searles Nielsen S, Turner JR, Racette BA (2023) Fine particulate matter and Parkinson Disease Risk among Medicare beneficiaries. Neurology 101(21):e2058\u2013e67. https:\/\/doi.org\/10.1212\/WNL.0000000000207871","journal-title":"Neurology"},{"issue":"2","key":"5402_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, O\u2019Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179\u2013194. https:\/\/doi.org\/10.1016\/S1474-4422(19)30356-4","journal-title":"Lancet Neurol"},{"issue":"1","key":"5402_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mds.27566","volume":"34","author":"A Ascherio","year":"2019","unstructured":"Ascherio A, Schwarzschild MA (2019) Lifestyle and Parkinson\u2019s disease progression. Mov Disord 34(1):7\u20138. https:\/\/doi.org\/10.1002\/mds.27566","journal-title":"Mov Disord"},{"issue":"10","key":"5402_CR10","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1007\/s00415-022-11190-z","volume":"269","author":"Y He","year":"2022","unstructured":"He Y, Peng K, Li R, Zhang Z, Pan L, Zhang T et al (2022) Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson\u2019s disease. J Neurol 269(10):5368\u20135381. https:\/\/doi.org\/10.1007\/s00415-022-11190-z","journal-title":"J Neurol"},{"key":"5402_CR11","doi-asserted-by":"publisher","first-page":"105744","DOI":"10.1016\/j.nbd.2022.105744","volume":"170","author":"M Bartl","year":"2022","unstructured":"Bartl M, Xylaki M, Bahr M, Weber S, Trenkwalder C, Mollenhauer B (2022) Evidence for immune system alterations in peripheral biological fluids in Parkinson\u2019s disease. Neurobiol Dis 170:105744. https:\/\/doi.org\/10.1016\/j.nbd.2022.105744","journal-title":"Neurobiol Dis"},{"issue":"11","key":"5402_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"5402_CR13","doi-asserted-by":"publisher","first-page":"102321","DOI":"10.1016\/j.arr.2024.102321","volume":"98","author":"K Singh","year":"2024","unstructured":"Singh K, Sethi P, Datta S, Chaudhary JS, Kumar S, Jain D et al (2024) Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases. Ageing Res Rev 98:102321. https:\/\/doi.org\/10.1016\/j.arr.2024.102321","journal-title":"Ageing Res Rev"},{"key":"5402_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2018.00114","volume":"12","author":"H Solleiro-Villavicencio","year":"2018","unstructured":"Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases. Front Cell Neurosci 12:114. https:\/\/doi.org\/10.3389\/fncel.2018.00114","journal-title":"Front Cell Neurosci"},{"key":"5402_CR15","doi-asserted-by":"publisher","unstructured":"Giri PM, Banerjee A, Ghosal A, Layek B (2024) Neuroinflammation in neurodegenerative disorders: current knowledge and therapeutic implications. Int J Mol Sci 25(7). https:\/\/doi.org\/10.3390\/ijms25073995","DOI":"10.3390\/ijms25073995"},{"issue":"1","key":"5402_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41421-021-00280-3","volume":"7","author":"P Wang","year":"2021","unstructured":"Wang P, Yao L, Luo M, Zhou W, Jin X, Xu Z et al (2021) Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson\u2019s disease. Cell Discov 7(1):52. https:\/\/doi.org\/10.1038\/s41421-021-00280-3","journal-title":"Cell Discov"},{"key":"5402_CR17","doi-asserted-by":"publisher","first-page":"617370","DOI":"10.3389\/fnagi.2021.617370","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen X, Feng W, Ou R, Liu J, Yang J, Fu J et al (2021) Evidence for Peripheral Immune activation in Parkinson\u2019s Disease. Front Aging Neurosci 13:617370. https:\/\/doi.org\/10.3389\/fnagi.2021.617370","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5402_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al (2009) Infiltration of CD4\u2009+\u2009lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182\u2013192. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Invest"},{"issue":"7","key":"5402_CR19","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144(7):2047\u20132059. https:\/\/doi.org\/10.1093\/brain\/awab103","journal-title":"Brain"},{"issue":"2","key":"5402_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","volume":"48","author":"BV Kumar","year":"2018","unstructured":"Kumar BV, Connors TJ, Farber DL, Human T (2018) Cell Development, localization, and function throughout life. Immunity 48(2):202\u2013213. https:\/\/doi.org\/10.1016\/j.immuni.2018.01.007","journal-title":"Immunity"},{"key":"5402_CR21","doi-asserted-by":"publisher","unstructured":"Zhu X, Zhu J (2020) CD4 T Helper Cell subsets and Related Human Immunological disorders. Int J Mol Sci 21(21). https:\/\/doi.org\/10.3390\/ijms21218011","DOI":"10.3390\/ijms21218011"},{"issue":"4","key":"5402_CR22","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1074\/jbc.270.4.1705","volume":"270","author":"T Bhattacharyya","year":"1995","unstructured":"Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B et al (1995) Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem 270(4):1705\u20131710. https:\/\/doi.org\/10.1074\/jbc.270.4.1705","journal-title":"J Biol Chem"},{"key":"5402_CR23","doi-asserted-by":"publisher","first-page":"521957doi","DOI":"10.1155\/2015\/521957","volume":"2015","author":"T Caza","year":"2015","unstructured":"Caza T, Landas S (2015) Functional and phenotypic plasticity of CD4(+) T cell subsets. Biomed Res Int 2015:521957doi. https:\/\/doi.org\/10.1155\/2015\/521957","journal-title":"Biomed Res Int"},{"key":"5402_CR24","doi-asserted-by":"publisher","first-page":"925135","DOI":"10.1155\/2012\/925135","volume":"2012","author":"RV Luckheeram","year":"2012","unstructured":"Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https:\/\/doi.org\/10.1155\/2012\/925135","journal-title":"Clin Dev Immunol"},{"key":"5402_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.001045","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"5402_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/s1074-7613(03)00296-6","volume":"19","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19(5):641\u2013644. https:\/\/doi.org\/10.1016\/s1074-7613(03)00296-6","journal-title":"Immunity"},{"issue":"3","key":"5402_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nri2038","volume":"7","author":"G Trinchieri","year":"2007","unstructured":"Trinchieri G, Sher A (2007) Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179\u2013190. https:\/\/doi.org\/10.1038\/nri2038","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5402_CR28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2012.09.007","volume":"37","author":"J Zhu","year":"2012","unstructured":"Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G et al (2012) The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37(4):660\u2013673. https:\/\/doi.org\/10.1016\/j.immuni.2012.09.007","journal-title":"Immunity"},{"key":"5402_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-020711-075058","volume":"30","author":"Y Kanno","year":"2012","unstructured":"Kanno Y, Vahedi G, Hirahara K, Singleton K, O\u2019Shea JJ (2012) Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30:707\u2013731. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075058","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"5402_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0952-7915(98)80163-5","volume":"10","author":"H Okamura","year":"1998","unstructured":"Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K (1998) Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10(3):259\u2013264. https:\/\/doi.org\/10.1016\/s0952-7915(98)80163-5","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"5402_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1172\/JCI31720","volume":"117","author":"I Gutcher","year":"2007","unstructured":"Gutcher I, Becher B (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117(5):1119\u20131127. https:\/\/doi.org\/10.1172\/JCI31720","journal-title":"J Clin Invest"},{"issue":"1","key":"5402_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-003-0186-x","volume":"193","author":"C Holscher","year":"2004","unstructured":"Holscher C (2004) The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 193(1):1\u201317. https:\/\/doi.org\/10.1007\/s00430-003-0186-x","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"5402_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100(6):655\u2013669. https:\/\/doi.org\/10.1016\/s0092-8674(00)80702-3","journal-title":"Cell"},{"issue":"2","key":"5402_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ni1424","volume":"8","author":"IM Djuretic","year":"2007","unstructured":"Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM (2007) Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 8(2):145\u2013153. https:\/\/doi.org\/10.1038\/ni1424","journal-title":"Nat Immunol"},{"issue":"12","key":"5402_CR35","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.4049\/jimmunol.0802527","volume":"183","author":"K Kohu","year":"2009","unstructured":"Kohu K, Ohmori H, Wong WF, Onda D, Wakoh T, Kon S et al (2009) The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J Immunol 183(12):7817\u20137824. https:\/\/doi.org\/10.4049\/jimmunol.0802527","journal-title":"J Immunol"},{"issue":"3","key":"5402_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s1074-7613(00)80439-2","volume":"4","author":"MH Kaplan","year":"1996","unstructured":"Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4(3):313\u2013319. https:\/\/doi.org\/10.1016\/s1074-7613(00)80439-2","journal-title":"Immunity"},{"issue":"12","key":"5402_CR37","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.4049\/jimmunol.166.12.7276","volume":"166","author":"J Zhu","year":"2001","unstructured":"Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE (2001) Stat6 is necessary and sufficient for IL-4\u2019s role in Th2 differentiation and cell expansion. J Immunol 166(12):7276\u20137281. https:\/\/doi.org\/10.4049\/jimmunol.166.12.7276","journal-title":"J Immunol"},{"issue":"7","key":"5402_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/intimm\/dxr029","volume":"23","author":"R Yagi","year":"2011","unstructured":"Yagi R, Zhu J, Paul WE (2011) An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol 23(7):415\u2013420. https:\/\/doi.org\/10.1093\/intimm\/dxr029","journal-title":"Int Immunol"},{"issue":"4","key":"5402_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri2735","volume":"10","author":"WE Paul","year":"2010","unstructured":"Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10(4):225\u2013235. https:\/\/doi.org\/10.1038\/nri2735","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"5402_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.immuni.2011.08.007","volume":"35","author":"G Wei","year":"2011","unstructured":"Wei G, Abraham BJ, Yagi R, Jothi R, Cui K, Sharma S et al (2011) Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35(2):299\u2013311. https:\/\/doi.org\/10.1016\/j.immuni.2011.08.007","journal-title":"Immunity"},{"issue":"11","key":"5402_CR41","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI57456","volume":"121","author":"EA Wohlfert","year":"2011","unstructured":"Wohlfert EA, Grainger JR, Bouladoux N, Konkel JE, Oldenhove G, Ribeiro CH et al (2011) GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J Clin Invest 121(11):4503\u20134515. https:\/\/doi.org\/10.1172\/JCI57456","journal-title":"J Clin Invest"},{"issue":"5","key":"5402_CR42","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1084\/jem.20171127","volume":"215","author":"D Fang","year":"2018","unstructured":"Fang D, Cui K, Hu G, Gurram RK, Zhong C, Oler AJ et al (2018) Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation. J Exp Med 215(5):1449\u20131462. https:\/\/doi.org\/10.1084\/jem.20171127","journal-title":"J Exp Med"},{"issue":"11","key":"5402_CR43","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni1128","volume":"5","author":"J Zhu","year":"2004","unstructured":"Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q et al (2004) Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5(11):1157\u20131165. https:\/\/doi.org\/10.1038\/ni1128","journal-title":"Nat Immunol"},{"issue":"3","key":"5402_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s1074-7613(03)00057-8","volume":"18","author":"T Usui","year":"2003","unstructured":"Usui T, Nishikomori R, Kitani A, Strober W (2003) GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity 18(3):415\u2013428. https:\/\/doi.org\/10.1016\/s1074-7613(03)00057-8","journal-title":"Immunity"},{"issue":"4","key":"5402_CR45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.immuni.2010.04.004","volume":"32","author":"R Yagi","year":"2010","unstructured":"Yagi R, Junttila IS, Wei G, Urban JF Jr., Zhao K, Paul WE et al (2010) The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma. Immunity 32(4):507\u2013517. https:\/\/doi.org\/10.1016\/j.immuni.2010.04.004","journal-title":"Immunity"},{"issue":"9","key":"5402_CR46","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.4049\/jimmunol.153.9.3989","volume":"153","author":"E Schmitt","year":"1994","unstructured":"Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S et al (1994) IL-9 production of naive CD4\u2009+\u2009T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol 153(9):3989\u20133996","journal-title":"J Immunol"},{"issue":"2","key":"5402_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","volume":"78","author":"Y Deng","year":"2017","unstructured":"Deng Y, Wang Z, Chang C, Lu L, Lau CS, Lu Q (2017) Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials. Hum Immunol 78(2):120\u2013128. https:\/\/doi.org\/10.1016\/j.humimm.2016.12.010","journal-title":"Hum Immunol"},{"issue":"3","key":"5402_CR48","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.4049\/jimmunol.1203089","volume":"191","author":"EE Kara","year":"2013","unstructured":"Kara EE, Comerford I, Bastow CR, Fenix KA, Litchfield W, Handel TM et al (2013) Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites. J Immunol 191(3):1110\u20131117. https:\/\/doi.org\/10.4049\/jimmunol.1203089","journal-title":"J Immunol"},{"issue":"3","key":"5402_CR49","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/0008-5472.CAN-14-2748","volume":"75","author":"F Vegran","year":"2015","unstructured":"Vegran F, Apetoh L, Ghiringhelli F (2015) Th9 cells: a novel CD4 T-cell subset in the immune war against cancer. Cancer Res 75(3):475\u2013479. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2748","journal-title":"Cancer Res"},{"issue":"11","key":"5402_CR50","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/JCI65459","volume":"122","author":"Y Lu","year":"2012","unstructured":"Lu Y, Hong S, Li H, Park J, Hong B, Wang L et al (2012) Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122(11):4160\u20134171. https:\/\/doi.org\/10.1172\/JCI65459","journal-title":"J Clin Invest"},{"issue":"1","key":"5402_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/imr.12028","volume":"252","author":"MH Kaplan","year":"2013","unstructured":"Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252(1):104\u2013115. https:\/\/doi.org\/10.1111\/imr.12028","journal-title":"Immunol Rev"},{"issue":"5","key":"5402_CR52","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.4049\/jimmunol.1300911","volume":"191","author":"R Anuradha","year":"2013","unstructured":"Anuradha R, George PJ, Hanna LE, Chandrasekaran V, Kumaran P, Nutman TB et al (2013) IL-4-, TGF-beta-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis. J Immunol 191(5):2466\u20132473. https:\/\/doi.org\/10.4049\/jimmunol.1300911","journal-title":"J Immunol"},{"issue":"29","key":"5402_CR53","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1038\/sj.onc.1208507","volume":"24","author":"MM Fung","year":"2005","unstructured":"Fung MM, Chu YL, Fink JL, Wallace A, McGuire KL (2005) IL-2- and STAT5-regulated cytokine gene expression in cells expressing the tax protein of HTLV-1. Oncogene 24(29):4624\u20134633. https:\/\/doi.org\/10.1038\/sj.onc.1208507","journal-title":"Oncogene"},{"issue":"1","key":"5402_CR54","doi-asserted-by":"publisher","first-page":"e0004317","DOI":"10.1371\/journal.pntd.0004317","volume":"10","author":"R Anuradha","year":"2016","unstructured":"Anuradha R, Munisankar S, Bhootra Y, Jagannathan J, Dolla C, Kumaran P et al (2016) IL-10- and TGFbeta-mediated Th9 responses in a human helminth infection. PLoS Negl Trop Dis 10(1):e0004317. https:\/\/doi.org\/10.1371\/journal.pntd.0004317","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"5402_CR55","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/icb.2010.73","volume":"88","author":"CS Ma","year":"2010","unstructured":"Ma CS, Tangye SG, Deenick EK (2010) Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21. Immunol Cell Biol 88(6):621\u2013623. https:\/\/doi.org\/10.1038\/icb.2010.73","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"5402_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.1846","volume":"11","author":"P Angkasekwinai","year":"2010","unstructured":"Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C (2010) Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 11(3):250\u2013256. https:\/\/doi.org\/10.1038\/ni.1846","journal-title":"Nat Immunol"},{"issue":"7","key":"5402_CR57","doi-asserted-by":"publisher","first-page":"e21695","DOI":"10.1371\/journal.pone.0021695","volume":"6","author":"L Blom","year":"2011","unstructured":"Blom L, Poulsen BC, Jensen BM, Hansen A, Poulsen LK (2011) IL-33 induces IL-9 production in human CD4\u2009+\u2009T cells and basophils. PLoS ONE 6(7):e21695. https:\/\/doi.org\/10.1371\/journal.pone.0021695","journal-title":"PLoS ONE"},{"issue":"1","key":"5402_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40425-018-0494-8","volume":"7","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen J, Bi E, Zhao Y, Qin T, Wang Y et al (2019) TNF-alpha enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways. J Immunother Cancer 7(1):28. https:\/\/doi.org\/10.1186\/s40425-018-0494-8","journal-title":"J Immunother Cancer"},{"issue":"11","key":"5402_CR59","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.4049\/jimmunol.1200808","volume":"189","author":"G Murugaiyan","year":"2012","unstructured":"Murugaiyan G, Beynon V, Pires Da Cunha A, Joller N, Weiner HL (2012) IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol 189(11):5277\u20135283. https:\/\/doi.org\/10.4049\/jimmunol.1200808","journal-title":"J Immunol"},{"issue":"3","key":"5402_CR60","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4049\/jimmunol.1102840","volume":"188","author":"R Goswami","year":"2012","unstructured":"Goswami R, Jabeen R, Yagi R, Pham D, Zhu J, Goenka S et al (2012) STAT6-dependent regulation of Th9 development. J Immunol 188(3):968\u2013975. https:\/\/doi.org\/10.4049\/jimmunol.1102840","journal-title":"J Immunol"},{"issue":"4","key":"5402_CR61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.it.2011.01.006","volume":"32","author":"NB Perumal","year":"2011","unstructured":"Perumal NB, Kaplan MH (2011) Regulating Il9 transcription in T helper cells. Trends Immunol 32(4):146\u2013150. https:\/\/doi.org\/10.1016\/j.it.2011.01.006","journal-title":"Trends Immunol"},{"issue":"12","key":"5402_CR62","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ni.1677","volume":"9","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA et al (2008) IL-4 inhibits TGF-beta-induced Foxp3\u2009+\u2009T cells and, together with TGF-beta, generates IL-9\u2009+\u2009IL-10\u2009+\u2009Foxp3(-) effector T cells. Nat Immunol 9(12):1347\u20131355. https:\/\/doi.org\/10.1038\/ni.1677","journal-title":"Nat Immunol"},{"issue":"2","key":"5402_CR63","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N et al (2010) Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33(2):192\u2013202. https:\/\/doi.org\/10.1016\/j.immuni.2010.07.014","journal-title":"Immunity"},{"issue":"4","key":"5402_CR64","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","volume":"36","author":"W Elyaman","year":"2012","unstructured":"Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B et al (2012) Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36(4):623\u2013634. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.020","journal-title":"Immunity"},{"issue":"11","key":"5402_CR65","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1172\/JCI69489","volume":"123","author":"R Jabeen","year":"2013","unstructured":"Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A et al (2013) Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 123(11):4641\u20134653. https:\/\/doi.org\/10.1172\/JCI69489","journal-title":"J Clin Invest"},{"issue":"6","key":"5402_CR66","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.4049\/jimmunol.1201496","volume":"189","author":"R Goswami","year":"2012","unstructured":"Goswami R, Kaplan MH (2012) Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells. J Immunol 189(6):3026\u20133033. https:\/\/doi.org\/10.4049\/jimmunol.1201496","journal-title":"J Immunol"},{"issue":"6","key":"5402_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.immuni.2005.03.016","volume":"22","author":"HC Chang","year":"2005","unstructured":"Chang HC, Zhang S, Thieu VT, Slee RB, Bruns HA, Laribee RN et al (2005) PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22(6):693\u2013703. https:\/\/doi.org\/10.1016\/j.immuni.2005.03.016","journal-title":"Immunity"},{"issue":"11","key":"5402_CR68","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6(11):1133\u20131141. https:\/\/doi.org\/10.1038\/ni1261","journal-title":"Nat Immunol"},{"issue":"5","key":"5402_CR69","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112(5):1557\u20131569. https:\/\/doi.org\/10.1182\/blood-2008-05-078154","journal-title":"Blood"},{"issue":"6","key":"5402_CR70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24(6):677\u2013688. https:\/\/doi.org\/10.1016\/j.immuni.2006.06.002","journal-title":"Immunity"},{"key":"5402_CR71","doi-asserted-by":"publisher","first-page":"932152","DOI":"10.3389\/fimmu.2022.932152","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi Y, Wei B, Li L, Wang B, Sun M (2022) Th17 cells and inflammation in neurological disorders: possible mechanisms of action. Front Immunol 13:932152. https:\/\/doi.org\/10.3389\/fimmu.2022.932152","journal-title":"Front Immunol"},{"issue":"9","key":"5402_CR72","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14(9):585\u2013600. https:\/\/doi.org\/10.1038\/nri3707","journal-title":"Nat Rev Immunol"},{"issue":"7090","key":"5402_CR73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235\u2013238. https:\/\/doi.org\/10.1038\/nature04753","journal-title":"Nature"},{"issue":"7090","key":"5402_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan PR, Harrington LE, O\u2019Quinn DB, Helms WS, Bullard DC, Elson CO et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231\u2013234. https:\/\/doi.org\/10.1038\/nature04754","journal-title":"Nature"},{"issue":"2","key":"5402_CR75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","volume":"24","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179\u2013189. https:\/\/doi.org\/10.1016\/j.immuni.2006.01.001","journal-title":"Immunity"},{"issue":"7152","key":"5402_CR76","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB et al (2007) IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448(7152):484\u2013487. https:\/\/doi.org\/10.1038\/nature05970","journal-title":"Nature"},{"issue":"9","key":"5402_CR77","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8(9):942\u2013949. https:\/\/doi.org\/10.1038\/ni1496","journal-title":"Nat Immunol"},{"issue":"6","key":"5402_CR78","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17\u2009+\u2009T helper cells. Cell 126(6):1121\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2006.07.035","journal-title":"Cell"},{"issue":"4","key":"5402_CR79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/08830185.2014.911858","volume":"34","author":"Y Tian","year":"2015","unstructured":"Tian Y, Wu Y, Ni B (2015) Signaling pathways and epigenetic regulations in the control of RORgammat expression in T Helper 17 cells. Int Rev Immunol 34(4):305\u2013317. https:\/\/doi.org\/10.3109\/08830185.2014.911858","journal-title":"Int Rev Immunol"},{"issue":"1","key":"5402_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28(1):29\u201339. https:\/\/doi.org\/10.1016\/j.immuni.2007.11.016","journal-title":"Immunity"},{"key":"5402_CR81","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531\u2013564. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141623","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"5402_CR82","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","volume":"193","author":"PA Taylor","year":"2001","unstructured":"Taylor PA, Noelle RJ, Blazar BR (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193(11):1311\u20131318. https:\/\/doi.org\/10.1084\/jem.193.11.1311","journal-title":"J Exp Med"},{"issue":"2","key":"5402_CR83","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/sji.12009","volume":"77","author":"B Gunnlaugsdottir","year":"2013","unstructured":"Gunnlaugsdottir B, Maggadottir SM, Skaftadottir I, Ludviksson BR (2013) The ex vivo induction of human CD103(+) CD25hi Foxp3(+) CD4(+) and CD8(+) Tregs is IL-2 and TGF-beta1 dependent. Scand J Immunol 77(2):125\u2013134. https:\/\/doi.org\/10.1111\/sji.12009","journal-title":"Scand J Immunol"},{"key":"5402_CR84","doi-asserted-by":"publisher","unstructured":"Blinova VG, Vasilyev VI, Rodionova EB, Zhdanov DD (2023) The Role of Regulatory T Cells in the Onset and Progression of Primary Sjogren\u2019s Syndrome. Cells 12(10). https:\/\/doi.org\/10.3390\/cells12101359","DOI":"10.3390\/cells12101359"},{"issue":"4","key":"5402_CR85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1189\/jlb.1107778","volume":"84","author":"TY Wuest","year":"2008","unstructured":"Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA (2008) The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol 84(4):973\u2013980. https:\/\/doi.org\/10.1189\/jlb.1107778","journal-title":"J Leukoc Biol"},{"key":"5402_CR86","doi-asserted-by":"publisher","first-page":"687669","DOI":"10.3389\/fimmu.2021.687669","volume":"12","author":"T MaruYama","year":"2021","unstructured":"MaruYama T, Kobayashi S, Nakatsukasa H, Moritoki Y, Taguchi D, Sunagawa Y et al (2021) The Curcumin Analog GO-Y030 controls the Generation and Stability of Regulatory T Cells. Front Immunol 12:687669. https:\/\/doi.org\/10.3389\/fimmu.2021.687669","journal-title":"Front Immunol"},{"issue":"8","key":"5402_CR87","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/eji.202048900","volume":"51","author":"TS Fulford","year":"2021","unstructured":"Fulford TS, Grumont R, Wirasinha RC, Ellis D, Barugahare A, Turner SJ et al (2021) c-Rel employs multiple mechanisms to promote the thymic development and peripheral function of regulatory T cells in mice. Eur J Immunol 51(8):2006\u20132026. https:\/\/doi.org\/10.1002\/eji.202048900","journal-title":"Eur J Immunol"},{"issue":"2","key":"5402_CR88","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ni.3646","volume":"18","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K, Kawakami R et al (2017) Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat Immunol 18(2):173\u2013183. https:\/\/doi.org\/10.1038\/ni.3646","journal-title":"Nat Immunol"},{"issue":"7","key":"5402_CR89","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.4049\/jimmunol.1402997","volume":"195","author":"T Lozano","year":"2015","unstructured":"Lozano T, Villanueva L, Durantez M, Gorraiz M, Ruiz M, Belsue V et al (2015) Inhibition of FOXP3\/NFAT Interaction enhances T cell function after TCR stimulation. J Immunol 195(7):3180\u20133189. https:\/\/doi.org\/10.4049\/jimmunol.1402997","journal-title":"J Immunol"},{"issue":"3","key":"5402_CR90","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ni.2520","volume":"14","author":"T Sekiya","year":"2013","unstructured":"Sekiya T, Kashiwagi I, Yoshida R, Fukaya T, Morita R, Kimura A et al (2013) Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 14(3):230\u2013237. https:\/\/doi.org\/10.1038\/ni.2520","journal-title":"Nat Immunol"},{"issue":"12","key":"5402_CR91","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.4049\/jimmunol.1201286","volume":"189","author":"AK Heninger","year":"2012","unstructured":"Heninger AK, Theil A, Wilhelm C, Petzold C, Huebel N, Kretschmer K et al (2012) IL-7 abrogates suppressive activity of human CD4\u2009+\u2009CD25\u2009+\u2009FOXP3\u2009+\u2009regulatory T cells and allows expansion of alloreactive and autoreactive T cells. J Immunol 189(12):5649\u20135658. https:\/\/doi.org\/10.4049\/jimmunol.1201286","journal-title":"J Immunol"},{"issue":"4","key":"5402_CR92","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s13238-017-0425-3","volume":"9","author":"C Apert","year":"2018","unstructured":"Apert C, Romagnoli P, van Meerwijk JPM (2018) IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes. Protein Cell 9(4):322\u2013332. https:\/\/doi.org\/10.1007\/s13238-017-0425-3","journal-title":"Protein Cell"},{"issue":"7136","key":"5402_CR93","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature05673","volume":"446","author":"M Ono","year":"2007","unstructured":"Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T et al (2007) Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1. Nature 446(7136):685\u2013689. https:\/\/doi.org\/10.1038\/nature05673","journal-title":"Nature"},{"issue":"13","key":"5402_CR94","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.7150\/thno.72148","volume":"12","author":"JN Chi","year":"2022","unstructured":"Chi JN, Yang JY, Hsueh CH, Tsai CY, Chuang HC, Tan TH (2022) MAP4K3\/GLK inhibits Treg differentiation by direct phosphorylating IKKbeta and inducing IKKbeta-mediated FoxO1 nuclear export and Foxp3 downregulation. Theranostics 12(13):5744\u20135760. https:\/\/doi.org\/10.7150\/thno.72148","journal-title":"Theranostics"},{"key":"5402_CR95","doi-asserted-by":"publisher","first-page":"1114780","DOI":"10.3389\/fimmu.2023.1114780","volume":"14","author":"L Morina","year":"2023","unstructured":"Morina L, Jones ME, Oguz C, Kaplan MJ, Gangaplara A, Fitzhugh CD et al (2023) Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease. Front Immunol 14:1114780. https:\/\/doi.org\/10.3389\/fimmu.2023.1114780","journal-title":"Front Immunol"},{"issue":"11","key":"5402_CR96","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","volume":"192","author":"D Breitfeld","year":"2000","unstructured":"Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M et al (2000) Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 192(11):1545\u20131552. https:\/\/doi.org\/10.1084\/jem.192.11.1545","journal-title":"J Exp Med"},{"issue":"11","key":"5402_CR97","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.192.11.1553","volume":"192","author":"P Schaerli","year":"2000","unstructured":"Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B (2000) CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192(11):1553\u20131562. https:\/\/doi.org\/10.1084\/jem.192.11.1553","journal-title":"J Exp Med"},{"issue":"4","key":"5402_CR98","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty S (2014) T follicular helper cell differentiation, function, and roles in disease. Immunity 41(4):529\u2013542. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.004","journal-title":"Immunity"},{"issue":"3","key":"5402_CR99","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","volume":"38","author":"D Baumjohann","year":"2013","unstructured":"Baumjohann D, Preite S, Reboldi A, Ronchi F, Ansel KM, Lanzavecchia A et al (2013) Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 38(3):596\u2013605. https:\/\/doi.org\/10.1016\/j.immuni.2012.11.020","journal-title":"Immunity"},{"issue":"6","key":"5402_CR100","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nri3447","volume":"13","author":"SG Tangye","year":"2013","unstructured":"Tangye SG, Ma CS, Brink R, Deenick EK (2013) The good, the bad and the ugly - TFH cells in human health and disease. Nat Rev Immunol 13(6):412\u2013426. https:\/\/doi.org\/10.1038\/nri3447","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"5402_CR101","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/all.12878","volume":"71","author":"G Varricchi","year":"2016","unstructured":"Varricchi G, Harker J, Borriello F, Marone G, Durham SR, Shamji MH (2016) T follicular helper (tfh) cells in normal immune responses and in allergic disorders. Allergy 71(8):1086\u20131094. https:\/\/doi.org\/10.1111\/all.12878","journal-title":"Allergy"},{"key":"5402_CR102","doi-asserted-by":"publisher","first-page":"1178792","DOI":"10.3389\/fimmu.2023.1178792","volume":"14","author":"J Qi","year":"2023","unstructured":"Qi J, Liu C, Bai Z, Li X, Yao G (2023) T follicular helper cells and T follicular regulatory cells in autoimmune diseases. Front Immunol 14:1178792. https:\/\/doi.org\/10.3389\/fimmu.2023.1178792","journal-title":"Front Immunol"},{"issue":"9","key":"5402_CR103","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41577-022-00693-5","volume":"22","author":"LSK Walker","year":"2022","unstructured":"Walker LSK (2022) The link between circulating follicular helper T cells and autoimmunity. Nat Rev Immunol 22(9):567\u2013575. https:\/\/doi.org\/10.1038\/s41577-022-00693-5","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5402_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/imm.13282","volume":"163","author":"L Dong","year":"2021","unstructured":"Dong L, He Y, Cao Y, Wang Y, Jia A, Wang Y et al (2021) Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity. Immunology 163(1):19\u201332. https:\/\/doi.org\/10.1111\/imm.13282","journal-title":"Immunology"},{"issue":"5","key":"5402_CR105","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"ST Crotty","year":"2019","unstructured":"Crotty ST, Follicular Helper (2019) Cell Biology: a decade of Discovery and diseases. Immunity 50(5):1132\u20131148. https:\/\/doi.org\/10.1016\/j.immuni.2019.04.011","journal-title":"Immunity"},{"key":"5402_CR106","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC (2016) Follicular helper T cells. Annu Rev Immunol 34:335\u2013368. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055605","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"5402_CR107","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.4049\/jimmunol.1203032","volume":"190","author":"YS Choi","year":"2013","unstructured":"Choi YS, Eto D, Yang JA, Lao C, Crotty S (2013) Cutting edge: STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation. J Immunol 190(7):3049\u20133053. https:\/\/doi.org\/10.4049\/jimmunol.1203032","journal-title":"J Immunol"},{"issue":"3","key":"5402_CR108","doi-asserted-by":"publisher","first-page":"e17739","DOI":"10.1371\/journal.pone.0017739","volume":"6","author":"D Eto","year":"2011","unstructured":"Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R et al (2011) IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (tfh) differentiation. PLoS ONE 6(3):e17739. https:\/\/doi.org\/10.1371\/journal.pone.0017739","journal-title":"PLoS ONE"},{"issue":"1","key":"5402_CR109","doi-asserted-by":"publisher","first-page":"13991","DOI":"10.1038\/s41598-019-50614-1","volume":"9","author":"MD Powell","year":"2019","unstructured":"Powell MD, Read KA, Sreekumar BK, Jones DM, Oestreich KJ (2019) IL-12 signaling drives the differentiation and function of a T(H)1-derived T(FH1)-like cell population. Sci Rep 9(1):13991. https:\/\/doi.org\/10.1038\/s41598-019-50614-1","journal-title":"Sci Rep"},{"issue":"1","key":"5402_CR110","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.immuni.2008.05.009","volume":"29","author":"RI Nurieva","year":"2008","unstructured":"Nurieva RI, Chung Y, Hwang D, Yang XO, Kang HS, Ma L et al (2008) Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29(1):138\u2013149. https:\/\/doi.org\/10.1016\/j.immuni.2008.05.009","journal-title":"Immunity"},{"issue":"4","key":"5402_CR111","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41385-019-0174-0","volume":"12","author":"F Moukambi","year":"2019","unstructured":"Moukambi F, Rabezanahary H, Fortier Y, Rodrigues V, Clain J, Benmadid-Laktout G et al (2019) Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27. Mucosal Immunol 12(4):1038\u20131054. https:\/\/doi.org\/10.1038\/s41385-019-0174-0","journal-title":"Mucosal Immunol"},{"key":"5402_CR112","doi-asserted-by":"publisher","unstructured":"DiToro D, Winstead CJ, Pham D, Witte S, Andargachew R, Singer JR et al (2018) Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells. Science 361(6407). https:\/\/doi.org\/10.1126\/science.aao2933","DOI":"10.1126\/science.aao2933"},{"issue":"3","key":"5402_CR113","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.4049\/jimmunol.1102948","volume":"189","author":"G Cai","year":"2012","unstructured":"Cai G, Nie X, Zhang W, Wu B, Lin J, Wang H et al (2012) A regulatory role for IL-10 receptor signaling in development and B cell help of T follicular helper cells in mice. J Immunol 189(3):1294\u20131302. https:\/\/doi.org\/10.4049\/jimmunol.1102948","journal-title":"J Immunol"},{"issue":"8","key":"5402_CR114","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.4049\/jimmunol.1701231","volume":"200","author":"PT Sage","year":"2018","unstructured":"Sage PT, Schildberg FA, Sobel RA, Kuchroo VK, Freeman GJ, Sharpe AH (2018) Dendritic cell PD-L1 limits autoimmunity and follicular T cell differentiation and function. J Immunol 200(8):2592\u20132602. https:\/\/doi.org\/10.4049\/jimmunol.1701231","journal-title":"J Immunol"},{"issue":"5943","key":"5402_CR115","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1176676","volume":"325","author":"RI Nurieva","year":"2009","unstructured":"Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, Matskevitch TD et al (2009) Bcl6 mediates the development of T follicular helper cells. Science 325(5943):1001\u20131005. https:\/\/doi.org\/10.1126\/science.1176676","journal-title":"Science"},{"issue":"10","key":"5402_CR116","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1084\/jem.20120219","volume":"209","author":"X Liu","year":"2012","unstructured":"Liu X, Yan X, Zhong B, Nurieva RI, Wang A, Wang X et al (2012) Bcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med 209(10):1841\u20131852. https:\/\/doi.org\/10.1084\/jem.20120219","journal-title":"J Exp Med"},{"issue":"17","key":"5402_CR117","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","volume":"119","author":"CS Ma","year":"2012","unstructured":"Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S et al (2012) Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 119(17):3997\u20134008. https:\/\/doi.org\/10.1182\/blood-2011-11-392985","journal-title":"Blood"},{"issue":"1","key":"5402_CR118","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20170457","volume":"215","author":"JS Weinstein","year":"2018","unstructured":"Weinstein JS, Laidlaw BJ, Lu Y, Wang JK, Schulz VP, Li N et al (2018) STAT4 and T-bet control follicular helper T cell development in viral infections. J Exp Med 215(1):337\u2013355. https:\/\/doi.org\/10.1084\/jem.20170457","journal-title":"J Exp Med"},{"issue":"22","key":"5402_CR119","doi-asserted-by":"publisher","first-page":"8664","DOI":"10.1073\/pnas.1205834109","volume":"109","author":"N Bollig","year":"2012","unstructured":"Bollig N, Brustle A, Kellner K, Ackermann W, Abass E, Raifer H et al (2012) Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc Natl Acad Sci U S A 109(22):8664\u20138669. https:\/\/doi.org\/10.1073\/pnas.1205834109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"5402_CR120","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.20091548","volume":"207","author":"BC Betz","year":"2010","unstructured":"Betz BC, Jordan-Williams KL, Wang C, Kang SG, Liao J, Logan MR et al (2010) Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J Exp Med 207(5):933\u2013942. https:\/\/doi.org\/10.1084\/jem.20091548","journal-title":"J Exp Med"},{"issue":"1","key":"5402_CR121","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li Y, Wang C, Han T, Liu H, Sun L et al (2023) The reciprocal interactions between microglia and T cells in Parkinson\u2019s disease: a double-edged sword. J Neuroinflammation 20(1):33. https:\/\/doi.org\/10.1186\/s12974-023-02723-y","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5402_CR122","doi-asserted-by":"publisher","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","volume":"2","author":"RL Mosley","year":"2012","unstructured":"Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE (2012) Inflammation and adaptive immunity in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(1):a009381. https:\/\/doi.org\/10.1101\/cshperspect.a009381","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5402_CR123","doi-asserted-by":"publisher","first-page":"593026","DOI":"10.3389\/fphys.2020.593026","volume":"11","author":"S Al-Bachari","year":"2020","unstructured":"Al-Bachari S, Naish JH, Parker GJM, Emsley HCA, Parkes LM (2020) Blood-brain barrier leakage is increased in Parkinson\u2019s Disease. Front Physiol 11:593026. https:\/\/doi.org\/10.3389\/fphys.2020.593026","journal-title":"Front Physiol"},{"issue":"29","key":"5402_CR124","doi-asserted-by":"publisher","first-page":"15267","DOI":"10.1074\/jbc.M116.714824","volume":"291","author":"G Chandra","year":"2016","unstructured":"Chandra G, Rangasamy SB, Roy A, Kordower JH, Pahan K (2016) Neutralization of RANTES and Eotaxin prevents the loss of dopaminergic neurons in a mouse model of Parkinson Disease. J Biol Chem 291(29):15267\u201315281. https:\/\/doi.org\/10.1074\/jbc.M116.714824","journal-title":"J Biol Chem"},{"issue":"11","key":"5402_CR125","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson Disease: a systematic review and Meta-analysis. JAMA Neurol 73(11):1316\u20131324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"issue":"6","key":"5402_CR126","doi-asserted-by":"publisher","first-page":"673","DOI":"10.14670\/HH-21.673","volume":"21","author":"H Arai","year":"2006","unstructured":"Arai H, Furuya T, Mizuno Y, Mochizuki H (2006) Inflammation and infection in Parkinson\u2019s disease. Histol Histopathol 21(6):673\u2013678. https:\/\/doi.org\/10.14670\/HH-21.673","journal-title":"Histol Histopathol"},{"issue":"2","key":"5402_CR127","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nrleng.2018.10.022","volume":"37","author":"S Garfias","year":"2022","unstructured":"Garfias S, Tamaya Dominguez B, Toledo Rojas A, Arroyo M, Rodriguez U, Boll C et al (2022) Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson\u2019s diseases. Neurologia (Engl Ed) 37(2):110\u2013121. https:\/\/doi.org\/10.1016\/j.nrleng.2018.10.022","journal-title":"Neurologia (Engl Ed)"},{"issue":"4","key":"5402_CR128","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","volume":"7","author":"JA Saunders","year":"2012","unstructured":"Saunders JA, Estes KA, Kosloski LM, Allen HE, Dempsey KM, Torres-Russotto DR et al (2012) CD4\u2009+\u2009regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease. J Neuroimmune Pharmacol 7(4):927\u2013938. https:\/\/doi.org\/10.1007\/s11481-012-9402-z","journal-title":"J Neuroimmune Pharmacol"},{"key":"5402_CR129","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbi.2020.07.005","volume":"89","author":"L Magistrelli","year":"2020","unstructured":"Magistrelli L, Storelli E, Rasini E, Contaldi E, Comi C, Cosentino M et al (2020) Relationship between circulating CD4\u2009+\u2009T lymphocytes and cognitive impairment in patients with Parkinson\u2019s disease. Brain Behav Immun 89:668\u2013674. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.005","journal-title":"Brain Behav Immun"},{"key":"5402_CR130","doi-asserted-by":"publisher","first-page":"769506","DOI":"10.3389\/fnagi.2021.769506","volume":"13","author":"R Su","year":"2021","unstructured":"Su R, Zhou T (2021) Alpha-Synuclein Induced Immune cells activation and Associated Therapy in Parkinson\u2019s Disease. Front Aging Neurosci 13:769506. https:\/\/doi.org\/10.3389\/fnagi.2021.769506","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"5402_CR131","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","volume":"10","author":"H Gonzalez","year":"2015","unstructured":"Gonzalez H, Contreras F, Pacheco R (2015) Regulation of the neurodegenerative process Associated to Parkinson\u2019s disease by CD4\u2009+\u2009T-cells. J Neuroimmune Pharmacol 10(4):561\u2013575. https:\/\/doi.org\/10.1007\/s11481-015-9618-9","journal-title":"J Neuroimmune Pharmacol"},{"issue":"Pt B","key":"5402_CR132","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.pnpbp.2017.07.023","volume":"79","author":"F Tahmasebinia","year":"2017","unstructured":"Tahmasebinia F, Pourgholaminejad A (2017) The role of Th17 cells in auto-inflammatory neurological disorders. Prog Neuropsychopharmacol Biol Psychiatry 79(Pt B):408\u2013416. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"5402_CR133","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mds.28137","volume":"36","author":"E De Francesco","year":"2021","unstructured":"De Francesco E, Terzaghi M, Storelli E, Magistrelli L, Comi C, Legnaro M et al (2021) CD4\u2009+\u2009T-cell transcription factors in idiopathic REM sleep behavior disorder and Parkinson\u2019s Disease. Mov Disord 36(1):225\u2013229. https:\/\/doi.org\/10.1002\/mds.28137","journal-title":"Mov Disord"},{"issue":"2","key":"5402_CR134","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JPD-202417","volume":"11","author":"E Contaldi","year":"2021","unstructured":"Contaldi E, Magistrelli L, Milner AV, Cosentino M, Marino F, Comi C (2021) Expression of transcription factors in CD4\u2009+\u2009T cells as potential biomarkers of Motor complications in Parkinson\u2019s Disease. J Parkinsons Dis 11(2):507\u2013514. https:\/\/doi.org\/10.3233\/JPD-202417","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"5402_CR135","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-022-02574-z","volume":"19","author":"SY Liu","year":"2022","unstructured":"Liu SY, Qiao HW, Song TB, Liu XL, Yao YX, Zhao CS et al (2022) Brain microglia activation and peripheral adaptive immunity in Parkinson\u2019s disease: a multimodal PET study. J Neuroinflammation 19(1):209. https:\/\/doi.org\/10.1186\/s12974-022-02574-z","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5402_CR136","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","volume":"15","author":"N Kustrimovic","year":"2018","unstructured":"Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R et al (2018) Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4\u2009+\u2009Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients. J Neuroinflammation 15(1):205. https:\/\/doi.org\/10.1186\/s12974-018-1248-8","journal-title":"J Neuroinflammation"},{"issue":"8","key":"5402_CR137","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","volume":"11","author":"Y Baba","year":"2005","unstructured":"Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T (2005) Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 11(8):493\u2013498. https:\/\/doi.org\/10.1016\/j.parkreldis.2005.07.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"5402_CR138","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/acn3.51420","volume":"8","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhuang J, Cai P, Li L, Wang R, Chen Z (2021) JKAP relates to disease risk, severity, and Th1 and Th17 differentiation in Parkinson\u2019s disease. Ann Clin Transl Neurol 8(9):1786\u20131795. https:\/\/doi.org\/10.1002\/acn3.51420","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"5402_CR139","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.3892\/mmr.2015.4136","volume":"12","author":"Y Chen","year":"2015","unstructured":"Chen Y, Qi B, Xu W, Ma B, Li L, Chen Q et al (2015) Clinical correlation of peripheral CD4+\u2013cell sub\u2013sets, their imbalance and Parkinson\u2019s disease. Mol Med Rep 12(4):6105\u20136111. https:\/\/doi.org\/10.3892\/mmr.2015.4136","journal-title":"Mol Med Rep"},{"issue":"1","key":"5402_CR140","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41531-022-00438-0","volume":"8","author":"D Mamula","year":"2022","unstructured":"Mamula D, Khosousi S, He Y, Lazarevic V, Svenningsson P (2022) Impaired migratory phenotype of CD4(+) T cells in Parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):171. https:\/\/doi.org\/10.1038\/s41531-022-00438-0","journal-title":"NPJ Parkinsons Dis"},{"issue":"4","key":"5402_CR141","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia C, Ros CM, Annese V, Gomez A, Ros-Bernal F, Aguado-Yera D et al (2011) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis 2(4):e142. https:\/\/doi.org\/10.1038\/cddis.2011.17","journal-title":"Cell Death Dis"},{"issue":"12","key":"5402_CR142","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R et al (2007) Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 27(12):3328\u20133337. https:\/\/doi.org\/10.1523\/JNEUROSCI.5321-06.2007","journal-title":"J Neurosci"},{"issue":"4","key":"5402_CR143","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1152\/advan.00066.2013","volume":"37","author":"ND Pennock","year":"2013","unstructured":"Pennock ND, White JT, Cross EW, Cheney EE, Tamburini BA, Kedl RM (2013) T cell responses: naive to memory and everything in between. Adv Physiol Educ 37(4):273\u2013283. https:\/\/doi.org\/10.1152\/advan.00066.2013","journal-title":"Adv Physiol Educ"},{"key":"5402_CR144","doi-asserted-by":"publisher","first-page":"666737","DOI":"10.3389\/fneur.2021.666737","volume":"12","author":"AN MacMahon Copas","year":"2021","unstructured":"MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA (2021) The pathogenesis of Parkinson\u2019s Disease: a complex interplay between astrocytes, Microglia, and T lymphocytes? Front Neurol 12:666737. https:\/\/doi.org\/10.3389\/fneur.2021.666737","journal-title":"Front Neurol"},{"issue":"1","key":"5402_CR145","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s40168-023-01685-w","volume":"11","author":"XB Bai","year":"2023","unstructured":"Bai XB, Xu S, Zhou LJ, Meng XQ, Li YL, Chen YL et al (2023) Oral pathogens exacerbate Parkinson\u2019s disease by promoting Th1 cell infiltration in mice. Microbiome 11(1):254. https:\/\/doi.org\/10.1186\/s40168-023-01685-w","journal-title":"Microbiome"},{"issue":"5","key":"5402_CR146","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.0901852","volume":"184","author":"AD Reynolds","year":"2010","unstructured":"Reynolds AD, Stone DK, Hutter JA, Benner EJ, Mosley RL, Gendelman HE (2010) Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson\u2019s disease. J Immunol 184(5):2261\u20132271. https:\/\/doi.org\/10.4049\/jimmunol.0901852","journal-title":"J Immunol"},{"issue":"6070","key":"5402_CR147","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/321610a0","volume":"321","author":"EN Benveniste","year":"1986","unstructured":"Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321(6070):610\u2013613. https:\/\/doi.org\/10.1038\/321610a0","journal-title":"Nature"},{"issue":"23","key":"5402_CR148","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1073\/pnas.83.23.9221","volume":"83","author":"RP Saneto","year":"1986","unstructured":"Saneto RP, Altman A, Knobler RL, Johnson HM, de Vellis J (1986) Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci U S A 83(23):9221\u20139225. https:\/\/doi.org\/10.1073\/pnas.83.23.9221","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5402_CR149","doi-asserted-by":"publisher","first-page":"166336doi","DOI":"10.1016\/j.bbadis.2021.166336","volume":"1868","author":"TJ Wenzel","year":"2022","unstructured":"Wenzel TJ, Haskey N, Kwong E, Greuel BK, Gates EJ, Gibson DL et al (2022) Dietary fats modulate neuroinflammation in mucin 2 knock out mice model of spontaneous colitis. Biochim Biophys Acta Mol Basis Dis 1868(3):166336doi. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166336","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1\u20132","key":"5402_CR150","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0006-8993(02)02740-3","volume":"944","author":"SS Zalcman","year":"2002","unstructured":"Zalcman SS (2002) Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res 944(1\u20132):157\u2013164. https:\/\/doi.org\/10.1016\/s0006-8993(02)02740-3","journal-title":"Brain Res"},{"issue":"3","key":"5402_CR151","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2011.05.230","volume":"499","author":"Z Huang","year":"2011","unstructured":"Huang Z, Meola D, Petitto JM (2011) Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells. Neurosci Lett 499(3):213\u2013218. https:\/\/doi.org\/10.1016\/j.neulet.2011.05.230","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"5402_CR152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett 202(1\u20132):17\u201320. https:\/\/doi.org\/10.1016\/0304-3940(95)12192-7","journal-title":"Neurosci Lett"},{"issue":"2","key":"5402_CR153","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s0165-5728(99)00093-4","volume":"98","author":"KP Wandinger","year":"1999","unstructured":"Wandinger KP, Hagenah JM, Kluter H, Rothermundt M, Peters M, Vieregge P (1999) Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson\u2019s disease. J Neuroimmunol 98(2):214\u2013220. https:\/\/doi.org\/10.1016\/s0165-5728(99)00093-4","journal-title":"J Neuroimmunol"},{"issue":"7","key":"5402_CR154","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR et al (2016) Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov Disord 31(7):995\u20131003. https:\/\/doi.org\/10.1002\/mds.26563","journal-title":"Mov Disord"},{"key":"5402_CR155","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jocn.2018.10.079","volume":"58","author":"R Kim","year":"2018","unstructured":"Kim R, Kim HJ, Kim A, Jang M, Kim A, Kim Y et al (2018) Peripheral blood inflammatory markers in early Parkinson\u2019s disease. J Clin Neurosci 58:30\u201333. https:\/\/doi.org\/10.1016\/j.jocn.2018.10.079","journal-title":"J Clin Neurosci"},{"issue":"4","key":"5402_CR156","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10517-020-04723-x","volume":"168","author":"IV Miliukhina","year":"2020","unstructured":"Miliukhina IV, Usenko TS, Senkevich KA, Nikolaev MA, Timofeeva AA, Agapova EA et al (2020) Plasma cytokines Profile in patients with Parkinson\u2019s Disease Associated with mutations in GBA Gene. Bull Exp Biol Med 168(4):423\u2013426. https:\/\/doi.org\/10.1007\/s10517-020-04723-x","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"5402_CR157","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.humimm.2022.11.001","volume":"84","author":"S Moradi","year":"2023","unstructured":"Moradi S, Zamani A, Mazdeh M, Ramezani M, Komaki A, Talebi-Ghane E et al (2023) An inclusive study on cytokine gene expression in Parkinson\u2019s disease: Advanced analysis using bayesian regression model. Hum Immunol 84(2):123\u2013129. https:\/\/doi.org\/10.1016\/j.humimm.2022.11.001","journal-title":"Hum Immunol"},{"key":"5402_CR158","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schroder","year":"2018","unstructured":"Schroder JB, Pawlowski M, Meyer Zu Horste G, Gross CC, Wiendl H, Meuth SG et al (2018) Immune Cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s Disease. Front Neurol 9:1081. https:\/\/doi.org\/10.3389\/fneur.2018.01081","journal-title":"Front Neurol"},{"issue":"1","key":"5402_CR159","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12883-021-02485-1","volume":"21","author":"S Martinez-Horta","year":"2021","unstructured":"Martinez-Horta S, Bejr-Kasem H, Horta-Barba A, Pascual-Sedano B, Santos-Garcia D, de Deus-Fonticoba T et al (2021) Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson\u2019s disease. BMC Neurol 21(1):477. https:\/\/doi.org\/10.1186\/s12883-021-02485-1","journal-title":"BMC Neurol"},{"issue":"2","key":"5402_CR160","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","volume":"219","author":"YJ Ho","year":"2011","unstructured":"Ho YJ, Ho SC, Pawlak CR, Yeh KY (2011) Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson\u2019s disease dementia. Behav Brain Res 219(2):280\u2013290. https:\/\/doi.org\/10.1016\/j.bbr.2011.01.028","journal-title":"Behav Brain Res"},{"key":"5402_CR161","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbi.2017.10.019","volume":"279","author":"ATR Goes","year":"2018","unstructured":"Goes ATR, Jesse CR, Antunes MS, Lobo Ladd FV, Lobo Ladd AAB, Luchese C et al (2018) Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson\u2019s disease: involvement of neuroinflammation and neurotrophins. Chem Biol Interact 279:111\u2013120. https:\/\/doi.org\/10.1016\/j.cbi.2017.10.019","journal-title":"Chem Biol Interact"},{"issue":"7","key":"5402_CR162","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","volume":"57","author":"MS Antunes","year":"2020","unstructured":"Antunes MS, Cattelan Souza L, Ladd FVL, Ladd A, Moreira AL, Bortolotto VC et al (2020) Hesperidin ameliorates anxiety-depressive-like Behavior in 6-OHDA model of Parkinson\u2019s disease by regulating Striatal Cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice. Mol Neurobiol 57(7):3027\u20133041. https:\/\/doi.org\/10.1007\/s12035-020-01940-3","journal-title":"Mol Neurobiol"},{"key":"5402_CR163","doi-asserted-by":"publisher","first-page":"1292555","DOI":"10.3389\/fmolb.2023.1292555","volume":"10","author":"S Zaichick","year":"2023","unstructured":"Zaichick S, Caraveo G, Harnessing (2023) IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in alpha-synucleinopathies. Front Mol Biosci 10:1292555. https:\/\/doi.org\/10.3389\/fmolb.2023.1292555","journal-title":"Front Mol Biosci"},{"issue":"7","key":"5402_CR164","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cellsig.2010.01.010","volume":"22","author":"KM Park","year":"2010","unstructured":"Park KM, Bowers WJ (2010) Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal 22(7):977\u2013983. https:\/\/doi.org\/10.1016\/j.cellsig.2010.01.010","journal-title":"Cell Signal"},{"issue":"2","key":"5402_CR165","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1073\/pnas.95.2.570","volume":"95","author":"M Grell","year":"1998","unstructured":"Grell M, Wajant H, Zimmermann G, Scheurich P (1998) The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A 95(2):570\u2013575. https:\/\/doi.org\/10.1073\/pnas.95.2.570","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"5402_CR166","first-page":"8","volume":"47","author":"M Grell","year":"1995","unstructured":"Grell M (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 47(1\u20132):8\u201317","journal-title":"J Inflamm"},{"key":"5402_CR167","doi-asserted-by":"publisher","unstructured":"Shateri S, Khatami SH, Haghbin Toutounchi A, Rajaei S, Mahdavi M, Mahmoodi Baram S et al (2023) Plasma cytokines profile in patients with Alzheimer\u2019s and Parkinson\u2019s Disease: a comparative study in terms of inflammation. Int J Neurosci 1\u201310. https:\/\/doi.org\/10.1080\/00207454.2023.2292951","DOI":"10.1080\/00207454.2023.2292951"},{"key":"5402_CR168","doi-asserted-by":"publisher","first-page":"9838295","DOI":"10.1155\/2020\/9838295","volume":"2020","author":"L Tang","year":"2020","unstructured":"Tang L, Chen C, Xia B, Wu W, Wei R, Zhu G et al (2020) Effect of Wenshen-Yanggan decoction on Movement Disorder and Substantia Nigra Dopaminergic Neurons in mice with chronic Parkinson\u2019s Disease. Evid Based Complement Alternat Med 2020:9838295. https:\/\/doi.org\/10.1155\/2020\/9838295","journal-title":"Evid Based Complement Alternat Med"},{"key":"5402_CR169","doi-asserted-by":"publisher","first-page":"134576","DOI":"10.1016\/j.neulet.2019.134576","volume":"714","author":"K Iwaoka","year":"2020","unstructured":"Iwaoka K, Otsuka C, Maeda T, Yamahara K, Kato K, Takahashi K et al (2020) Impaired metabolism of kynurenine and its metabolites in CSF of parkinson\u2019s disease. Neurosci Lett 714:134576. https:\/\/doi.org\/10.1016\/j.neulet.2019.134576","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"5402_CR170","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-x","volume":"172","author":"G Boka","year":"1994","unstructured":"Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease. Neurosci Lett 172(1\u20132):151\u2013154. https:\/\/doi.org\/10.1016\/0304-3940(94)90684-x","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"5402_CR171","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165(1\u20132):208\u2013210. https:\/\/doi.org\/10.1016\/0304-3940(94)90746-3","journal-title":"Neurosci Lett"},{"issue":"8","key":"5402_CR172","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.parkreldis.2008.02.001","volume":"14","author":"M Bialecka","year":"2008","unstructured":"Bialecka M, Klodowska-Duda G, Kurzawski M, Slawek J, Gorzkowska A, Opala G et al (2008) Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson\u2019s disease patients. Parkinsonism Relat Disord 14(8):636\u2013640. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.02.001","journal-title":"Parkinsonism Relat Disord"},{"key":"5402_CR173","doi-asserted-by":"publisher","first-page":"578222","DOI":"10.1016\/j.jneuroim.2023.578222","volume":"385","author":"L Wang","year":"2023","unstructured":"Wang L, Yi H, Liang X, Xu F, Li T, Yang X et al (2023) Plasma TNF-alpha and phosphorylated alpha-syn are associated with fatigue in patients with Parkinson\u2019s disease. J Neuroimmunol 385:578222. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578222","journal-title":"J Neuroimmunol"},{"key":"5402_CR174","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","volume":"166","author":"E Kouchaki","year":"2018","unstructured":"Kouchaki E, Kakhaki RD, Tamtaji OR, Dadgostar E, Behnam M, Nikoueinejad H et al (2018) Increased serum levels of TNF-alpha and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg 166:76\u201379. https:\/\/doi.org\/10.1016\/j.clineuro.2018.01.022","journal-title":"Clin Neurol Neurosurg"},{"key":"5402_CR175","doi-asserted-by":"publisher","unstructured":"Xiromerisiou G, Marogianni C, Lampropoulos IC, Dardiotis E, Speletas M, Ntavaroukas P et al (2022) Peripheral Inflammatory Markers TNF-alpha and CCL2 Revisited: Association with Parkinson\u2019s Disease Severity. Int J Mol Sci 24(1). https:\/\/doi.org\/10.3390\/ijms24010264","DOI":"10.3390\/ijms24010264"},{"issue":"5","key":"5402_CR176","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00702-004-0222-z","volume":"112","author":"PM Carvey","year":"2005","unstructured":"Carvey PM, Chen EY, Lipton JW, Tong CW, Chang QA, Ling ZD (2005) Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat. J Neural Transm (Vienna) 112(5):601\u2013612. https:\/\/doi.org\/10.1007\/s00702-004-0222-z","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"5402_CR177","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM (2007) TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 26(1):36\u201346. https:\/\/doi.org\/10.1016\/j.nbd.2006.11.012","journal-title":"Neurobiol Dis"},{"issue":"2","key":"5402_CR178","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.expneurol.2010.11.010","volume":"227","author":"M Chertoff","year":"2011","unstructured":"Chertoff M, Di Paolo N, Schoeneberg A, Depino A, Ferrari C, Wurst W et al (2011) Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor alpha in the nigrostriatal dopaminergic circuit of adult mice. Exp Neurol 227(2):237\u2013251. https:\/\/doi.org\/10.1016\/j.expneurol.2010.11.010","journal-title":"Exp Neurol"},{"issue":"1","key":"5402_CR179","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mt.2010.217","volume":"19","author":"AS Harms","year":"2011","unstructured":"Harms AS, Barnum CJ, Ruhn KA, Varghese S, Trevino I, Blesch A et al (2011) Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson\u2019s disease. Mol Ther 19(1):46\u201352. https:\/\/doi.org\/10.1038\/mt.2010.217","journal-title":"Mol Ther"},{"issue":"3","key":"5402_CR180","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O\u2019Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96(3):706\u2013718. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03566.x","journal-title":"J Neurochem"},{"issue":"11","key":"5402_CR181","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","volume":"16","author":"K Sriram","year":"2002","unstructured":"Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O\u2019Callaghan JP (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease. FASEB J 16(11):1474\u20131476. https:\/\/doi.org\/10.1096\/fj.02-0216fje","journal-title":"FASEB J"},{"issue":"30","key":"5402_CR182","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","volume":"281","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R et al (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281(30):21362\u201321368. https:\/\/doi.org\/10.1074\/jbc.M600504200","journal-title":"J Biol Chem"},{"issue":"3","key":"5402_CR183","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1038\/cddis.2013.59","volume":"4","author":"J Guadagno","year":"2013","unstructured":"Guadagno J, Xu X, Karajgikar M, Brown A, Cregan SP (2013) Microglia-derived TNFalpha induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma. Cell Death Dis 4(3):e538. https:\/\/doi.org\/10.1038\/cddis.2013.59","journal-title":"Cell Death Dis"},{"issue":"4","key":"5402_CR184","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jnc.13008","volume":"132","author":"DN Doll","year":"2015","unstructured":"Doll DN, Rellick SL, Barr TL, Ren X, Simpkins JW (2015) Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity. J Neurochem 132(4):443\u2013451. https:\/\/doi.org\/10.1111\/jnc.13008","journal-title":"J Neurochem"},{"key":"5402_CR185","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2015.05.008","volume":"271","author":"MX Wang","year":"2015","unstructured":"Wang MX, Cheng XY, Jin M, Cao YL, Yang YP, Wang JD et al (2015) TNF compromises lysosome acidification and reduces alpha-synuclein degradation via autophagy in dopaminergic cells. Exp Neurol 271:112\u2013121. https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.008","journal-title":"Exp Neurol"},{"issue":"6","key":"5402_CR186","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s12276-022-00789-x","volume":"54","author":"EJ Bae","year":"2022","unstructured":"Bae EJ, Choi M, Kim JT, Kim DK, Jung MK, Kim C et al (2022) TNF-alpha promotes alpha-synuclein propagation through stimulation of senescence-associated lysosomal exocytosis. Exp Mol Med 54(6):788\u2013800. https:\/\/doi.org\/10.1038\/s12276-022-00789-x","journal-title":"Exp Mol Med"},{"issue":"2","key":"5402_CR187","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","volume":"2","author":"K Sriram","year":"2007","unstructured":"Sriram K, O\u2019Callaghan JP (2007) Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2(2):140\u2013153. https:\/\/doi.org\/10.1007\/s11481-007-9070-6","journal-title":"J Neuroimmune Pharmacol"},{"issue":"12","key":"5402_CR188","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.tins.2022.10.007","volume":"45","author":"O Kann","year":"2022","unstructured":"Kann O, Almouhanna F, Chausse B (2022) Interferon gamma: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci 45(12):913\u2013927. https:\/\/doi.org\/10.1016\/j.tins.2022.10.007","journal-title":"Trends Neurosci"},{"key":"5402_CR189","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2023.04.008","volume":"111","author":"BD Hobson","year":"2023","unstructured":"Hobson BD, Stanley AT, De Los Santos MB, Culbertson B, Mosharov EV, Sims PA et al (2023) Conserved and cell type-specific transcriptional responses to IFN-gamma in the ventral midbrain. Brain Behav Immun 111:277\u2013291. https:\/\/doi.org\/10.1016\/j.bbi.2023.04.008","journal-title":"Brain Behav Immun"},{"issue":"12","key":"5402_CR190","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1002\/glia.23878","volume":"68","author":"J Zhang","year":"2020","unstructured":"Zhang J, He H, Qiao Y, Zhou T, He H, Yi S et al (2020) Priming of microglia with IFN-gamma impairs adult hippocampal neurogenesis and leads to depression-like behaviors and cognitive defects. Glia 68(12):2674\u20132692. https:\/\/doi.org\/10.1002\/glia.23878","journal-title":"Glia"},{"issue":"1\u20132","key":"5402_CR191","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0165-5728(97)00034-9","volume":"76","author":"W Pan","year":"1997","unstructured":"Pan W, Banks WA, Kastin AJ (1997) Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol 76(1\u20132):105\u2013111. https:\/\/doi.org\/10.1016\/s0165-5728(97)00034-9","journal-title":"J Neuroimmunol"},{"issue":"12","key":"5402_CR192","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.neurobiolaging.2008.02.019","volume":"30","author":"S Hashioka","year":"2009","unstructured":"Hashioka S, Klegeris A, Schwab C, McGeer PL (2009) Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging 30(12):1924\u20131935. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.02.019","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5402_CR193","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP et al (2019) Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation 16(1):129. https:\/\/doi.org\/10.1186\/s12974-019-1528-y","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5402_CR194","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","volume":"55","author":"NP Rocha","year":"2018","unstructured":"Rocha NP, Assis F, Scalzo PL, Vieira ELM, Barbosa IG, de Souza MS et al (2018) Reduced activated T lymphocytes (CD4\u2009+\u2009CD25+) and plasma levels of cytokines in Parkinson\u2019s Disease. Mol Neurobiol 55(2):1488\u20131497. https:\/\/doi.org\/10.1007\/s12035-017-0404-y","journal-title":"Mol Neurobiol"},{"key":"5402_CR195","doi-asserted-by":"publisher","first-page":"100442","DOI":"10.1016\/j.bbih.2022.100442","volume":"21","author":"K Diaz","year":"2022","unstructured":"Diaz K, Kohut ML, Russell DW, Stegemoller EL (2022) Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson\u2019s disease. Brain Behav Immun Health 21:100442. https:\/\/doi.org\/10.1016\/j.bbih.2022.100442","journal-title":"Brain Behav Immun Health"},{"key":"5402_CR196","doi-asserted-by":"publisher","unstructured":"Wang N, Li R, Feng B, Cheng Y, Guo Y, Qian H (2022) Chicoric Acid Prevents Neuroinflammation and Neurodegeneration in a Mouse Parkinson\u2019s Disease Model: Immune Response and Transcriptome Profile of the Spleen and Colon. Int J Mol Sci 23(4). https:\/\/doi.org\/10.3390\/ijms23042031","DOI":"10.3390\/ijms23042031"},{"key":"5402_CR197","doi-asserted-by":"publisher","unstructured":"Chen CM, Yen CY, Chen WL, Lin CH, Wu YR, Chang KH et al (2021) Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson\u2019s Disease Targeting Neuroinflammation. Int J Mol Sci 22(3). https:\/\/doi.org\/10.3390\/ijms22031062","DOI":"10.3390\/ijms22031062"},{"key":"5402_CR198","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ibror.2019.12.002","volume":"8","author":"A Rodriguez-Cruz","year":"2020","unstructured":"Rodriguez-Cruz A, Romo-Mancillas A, Mendiola-Precoma J, Escobar-Cabrera JE, Garcia-Alcocer G, Berumen LC (2020) Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson\u2019s disease. IBRO Rep 8:28\u201335. https:\/\/doi.org\/10.1016\/j.ibror.2019.12.002","journal-title":"IBRO Rep"},{"issue":"6","key":"5402_CR199","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nn.2829","volume":"14","author":"P Chakrabarty","year":"2011","unstructured":"Chakrabarty P, Ceballos-Diaz C, Lin WL, Beccard A, Jansen-West K, McFarland NR et al (2011) Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification. Nat Neurosci 14(6):694\u2013696. https:\/\/doi.org\/10.1038\/nn.2829","journal-title":"Nat Neurosci"},{"issue":"4","key":"5402_CR200","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1080\/21655979.2022.2068754","volume":"13","author":"X Xue","year":"2022","unstructured":"Xue X, Duan R, Zheng G, Chen H, Zhang W, Shi L (2022) Translocator protein (18\u00a0kDa) regulates the microglial phenotype in Parkinson\u2019s disease through P47. Bioengineered 13(4):11061\u201311071. https:\/\/doi.org\/10.1080\/21655979.2022.2068754","journal-title":"Bioengineered"},{"issue":"6","key":"5402_CR201","doi-asserted-by":"publisher","first-page":"e21519","DOI":"10.1371\/journal.pone.0021519","volume":"6","author":"J Thevenet","year":"2011","unstructured":"Thevenet J, Pescini Gobert R, van Hooft R, Wiessner C, Sagot YJ (2011) Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS ONE 6(6):e21519. https:\/\/doi.org\/10.1371\/journal.pone.0021519","journal-title":"PLoS ONE"},{"issue":"6","key":"5402_CR202","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/jnc.12668","volume":"129","author":"M Kuss","year":"2014","unstructured":"Kuss M, Adamopoulou E, Kahle PJ (2014) Interferon-gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages. J Neurochem 129(6):980\u2013987. https:\/\/doi.org\/10.1111\/jnc.12668","journal-title":"J Neurochem"},{"issue":"1","key":"5402_CR203","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1038\/s41467-020-18755-4","volume":"11","author":"V Panagiotakopoulou","year":"2020","unstructured":"Panagiotakopoulou V, Ivanyuk D, De Cicco S, Haq W, Arsic A, Yu C et al (2020) Interferon-gamma signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells. Nat Commun 11(1):5163. https:\/\/doi.org\/10.1038\/s41467-020-18755-4","journal-title":"Nat Commun"},{"issue":"1","key":"5402_CR204","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12883-019-1286-6","volume":"19","author":"D Rathnayake","year":"2019","unstructured":"Rathnayake D, Chang T, Udagama P (2019) Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC Neurol 19(1):56. https:\/\/doi.org\/10.1186\/s12883-019-1286-6","journal-title":"BMC Neurol"},{"issue":"2","key":"5402_CR205","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.imbio.2015.10.002","volume":"221","author":"A Shameli","year":"2016","unstructured":"Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson HJ et al (2016) A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology 221(2):333\u2013340. https:\/\/doi.org\/10.1016\/j.imbio.2015.10.002","journal-title":"Immunobiology"},{"issue":"5","key":"5402_CR206","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","volume":"207","author":"NC Derecki","year":"2010","unstructured":"Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR et al (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207(5):1067\u20131080. https:\/\/doi.org\/10.1084\/jem.20091419","journal-title":"J Exp Med"},{"issue":"10","key":"5402_CR207","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2008.07.007","volume":"29","author":"J Kipnis","year":"2008","unstructured":"Kipnis J, Derecki NC, Yang C, Scrable H (2008) Immunity and cognition: what do age-related dementia, HIV-dementia and \u2018chemo-brain\u2019 have in common? Trends Immunol 29(10):455\u2013463. https:\/\/doi.org\/10.1016\/j.it.2008.07.007","journal-title":"Trends Immunol"},{"issue":"7","key":"5402_CR208","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.4049\/jimmunol.1601546","volume":"198","author":"TM Brombacher","year":"2017","unstructured":"Brombacher TM, Nono JK, De Gouveia KS, Makena N, Darby M, Womersley J et al (2017) IL-13-Mediated regulation of learning and memory. J Immunol 198(7):2681\u20132688. https:\/\/doi.org\/10.4049\/jimmunol.1601546","journal-title":"J Immunol"},{"issue":"1","key":"5402_CR209","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1080\/07853890.2023.2188487","volume":"55","author":"F Chen","year":"2023","unstructured":"Chen F, Wang Y, Chen X, Yang N, Li L (2023) Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid. Ann Med 55(1):1156\u20131170. https:\/\/doi.org\/10.1080\/07853890.2023.2188487","journal-title":"Ann Med"},{"issue":"1\u20134","key":"5402_CR210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830189809084486","volume":"17","author":"P Chomarat","year":"1998","unstructured":"Chomarat P, Banchereau J (1998) Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 17(1\u20134):1\u201352. https:\/\/doi.org\/10.3109\/08830189809084486","journal-title":"Int Rev Immunol"},{"key":"5402_CR211","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","volume":"9","author":"IS Junttila","year":"2018","unstructured":"Junttila IS (2018) Tuning the cytokine responses: an update on Interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol 9:888. https:\/\/doi.org\/10.3389\/fimmu.2018.00888","journal-title":"Front Immunol"},{"issue":"4","key":"5402_CR212","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/glia.10057","volume":"38","author":"MS Yang","year":"2002","unstructured":"Yang MS, Park EJ, Sohn S, Kwon HJ, Shin WH, Pyo HK et al (2002) Interleukin-13 and \u2013\u20094 induce death of activated microglia. Glia 38(4):273\u2013280. https:\/\/doi.org\/10.1002\/glia.10057","journal-title":"Glia"},{"issue":"4","key":"5402_CR213","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s13311-019-00761-0","volume":"16","author":"N Kolosowska","year":"2019","unstructured":"Kolosowska N, Keuters MH, Wojciechowski S, Keksa-Goldsteine V, Laine M, Malm T et al (2019) Peripheral Administration of IL-13 induces anti-inflammatory Microglial\/Macrophage responses and provides neuroprotection in ischemic stroke. Neurotherapeutics 16(4):1304\u20131319. https:\/\/doi.org\/10.1007\/s13311-019-00761-0","journal-title":"Neurotherapeutics"},{"issue":"1","key":"5402_CR214","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12974-022-02471-5","volume":"19","author":"D Chen","year":"2022","unstructured":"Chen D, Li J, Huang Y, Wei P, Miao W, Yang Y et al (2022) Interleukin 13 promotes long-term recovery after ischemic stroke by inhibiting the activation of STAT3. J Neuroinflammation 19(1):112. https:\/\/doi.org\/10.1186\/s12974-022-02471-5","journal-title":"J Neuroinflammation"},{"key":"5402_CR215","doi-asserted-by":"publisher","first-page":"104814","DOI":"10.1016\/j.nbd.2020.104814","volume":"140","author":"L Yang","year":"2020","unstructured":"Yang L, Zhou R, Tong Y, Chen P, Shen Y, Miao S et al (2020) Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation. Neurobiol Dis 140:104814. https:\/\/doi.org\/10.1016\/j.nbd.2020.104814","journal-title":"Neurobiol Dis"},{"key":"5402_CR216","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2018.04.018","volume":"320","author":"MK Cobourne-Duval","year":"2018","unstructured":"Cobourne-Duval MK, Taka E, Mendonca P, Soliman KFA (2018) Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFkappaB pathway signaling targets in LPS\/IFNgamma -activated BV-2 microglia cells. J Neuroimmunol 320:87\u201397. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.018","journal-title":"J Neuroimmunol"},{"issue":"3","key":"5402_CR217","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s12035-017-0491-9","volume":"55","author":"P Tripathi","year":"2018","unstructured":"Tripathi P, Singh A, Bala L, Patel DK, Singh MP (2018) Ibuprofen protects from Cypermethrin-Induced changes in the Striatal dendritic length and spine density. Mol Neurobiol 55(3):2333\u20132339. https:\/\/doi.org\/10.1007\/s12035-017-0491-9","journal-title":"Mol Neurobiol"},{"issue":"12","key":"5402_CR218","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.4049\/jimmunol.1102150","volume":"189","author":"BE Morrison","year":"2012","unstructured":"Morrison BE, Marcondes MC, Nomura DK, Sanchez-Alavez M, Sanchez-Gonzalez A, Saar I et al (2012) Cutting edge: IL-13Ralpha1 expression in dopaminergic neurons contributes to their oxidative stress-mediated loss following chronic peripheral treatment with lipopolysaccharide. J Immunol 189(12):5498\u20135502. https:\/\/doi.org\/10.4049\/jimmunol.1102150","journal-title":"J Immunol"},{"issue":"1","key":"5402_CR219","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12974-017-0862-1","volume":"14","author":"S Mori","year":"2017","unstructured":"Mori S, Sugama S, Nguyen W, Michel T, Sanna MG, Sanchez-Alavez M et al (2017) Lack of interleukin-13 receptor alpha1 delays the loss of dopaminergic neurons during chronic stress. J Neuroinflammation 14(1):88. https:\/\/doi.org\/10.1186\/s12974-017-0862-1","journal-title":"J Neuroinflammation"},{"key":"5402_CR220","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.bbi.2020.04.007","volume":"88","author":"CA Aguirre","year":"2020","unstructured":"Aguirre CA, Concetta Morale M, Peng Q, Sanchez-Alavez M, Cintron-Colon R, Feng K et al (2020) Two single nucleotide polymorphisms in IL13 and IL13RA1 from individuals with idiopathic Parkinson\u2019s disease increase cellular susceptibility to oxidative stress. Brain Behav Immun 88:920\u2013924. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.007","journal-title":"Brain Behav Immun"},{"key":"5402_CR221","doi-asserted-by":"publisher","unstructured":"Yan Z, Yang W, Wei H, Dean MN, Standaert DG, Cutter GR et al (2021) Dysregulation of the adaptive Immune System in patients with early-stage Parkinson Disease. Neurol Neuroimmunol Neuroinflamm 8(5). https:\/\/doi.org\/10.1212\/NXI.0000000000001036","DOI":"10.1212\/NXI.0000000000001036"},{"issue":"2","key":"5402_CR222","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki B, Staszewski J, Toczylowska B, Kozlowska E, Drela N, Chalimoniuk M et al (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441(2):158\u2013162. https:\/\/doi.org\/10.1016\/j.neulet.2008.06.040","journal-title":"Neurosci Lett"},{"key":"5402_CR223","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fnagi.2018.00392","volume":"10","author":"T Li","year":"2018","unstructured":"Li T, Yang Z, Li S, Cheng C, Shen B, Le W (2018) Alterations of NURR1 and cytokines in the peripheral blood mononuclear cells: combined biomarkers for Parkinson\u2019s Disease. Front Aging Neurosci 10:392. https:\/\/doi.org\/10.3389\/fnagi.2018.00392","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5402_CR224","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","volume":"16","author":"DD Alvarez-Luquin","year":"2019","unstructured":"Alvarez-Luquin DD, Arce-Sillas A, Leyva-Hernandez J, Sevilla-Reyes E, Boll MC, Montes-Moratilla E et al (2019) Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs: other regulatory populations are also involved. J Neuroinflammation 16(1):212. https:\/\/doi.org\/10.1186\/s12974-019-1606-1","journal-title":"J Neuroinflammation"},{"issue":"6","key":"5402_CR225","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s11011-023-01230-6","volume":"38","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani S, Khoshnam SE, Mansouri E, Ghafouri S, Bakhtiari N, Farbood Y et al (2023) Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson\u2019s disease-like motor and non-motor symptoms induced by rotenone in rats. Metab Brain Dis 38(6):2159\u20132174. https:\/\/doi.org\/10.1007\/s11011-023-01230-6","journal-title":"Metab Brain Dis"},{"issue":"2Supplementary","key":"5402_CR226","first-page":"755","volume":"33","author":"AA Zaidi","year":"2020","unstructured":"Zaidi AA, Khan MA, Shahreyar ZA, Ahmed H (2020) Lauric acid: its role in behavioral modulation, neuro-inflammatory and oxidative stress markers in haloperidol induced Parkinson\u2019s disease. Pak J Pharm Sci 33(2Supplementary):755\u2013763","journal-title":"Pak J Pharm Sci"},{"key":"5402_CR227","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnmol.2017.00062","volume":"10","author":"L Huhner","year":"2017","unstructured":"Huhner L, Rilka J, Gilsbach R, Zhou X, Machado V, Spittau B (2017) Interleukin-4 protects dopaminergic neurons in vitro but is dispensable for MPTP-Induced Neurodegeneration in vivo. Front Mol Neurosci 10:62. https:\/\/doi.org\/10.3389\/fnmol.2017.00062","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"5402_CR228","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4103\/1673-5374.215250","volume":"12","author":"B Spittau","year":"2017","unstructured":"Spittau B (2017) Interleukin 4-induced neuroprotection and regulation of microglia activation as a therapeutic approach in the MPTP model of Parkinson\u2019s disease. Neural Regen Res 12(9):1433\u20131434. https:\/\/doi.org\/10.4103\/1673-5374.215250","journal-title":"Neural Regen Res"},{"issue":"4","key":"5402_CR229","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5607\/en.2018.27.4.309","volume":"27","author":"E Bok","year":"2018","unstructured":"Bok E, Cho EJ, Chung ES, Shin WH, Jin BK (2018) Interleukin-4 contributes to degeneration of dopamine neurons in the Lipopolysaccharide-treated Substantia Nigra in vivo. Exp Neurobiol 27(4):309\u2013319. https:\/\/doi.org\/10.5607\/en.2018.27.4.309","journal-title":"Exp Neurobiol"},{"issue":"9","key":"5402_CR230","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s12276-021-00660-5","volume":"53","author":"SS Yeung","year":"2021","unstructured":"Yeung SS, Ho YS, Chang RC (2021) The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases. Exp Mol Med 53(9):1251\u20131267. https:\/\/doi.org\/10.1038\/s12276-021-00660-5","journal-title":"Exp Mol Med"},{"issue":"7","key":"5402_CR231","doi-asserted-by":"publisher","first-page":"CD010834","DOI":"10.1002\/14651858.CD010834.pub4","volume":"7","author":"HA Farne","year":"2022","unstructured":"Farne HA, Wilson A, Milan S, Banchoff E, Yang F, Powell CV (2022) Anti-IL-5 therapies for asthma. Cochrane Database Syst Rev 7(7):CD010834. https:\/\/doi.org\/10.1002\/14651858.CD010834.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"5402_CR232","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/alr.22994","volume":"12","author":"P Gevaert","year":"2022","unstructured":"Gevaert P, Han JK, Smith SG, Sousa AR, Howarth PH, Yancey SW et al (2022) The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 12(11):1413\u20131423. https:\/\/doi.org\/10.1002\/alr.22994","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"5402_CR233","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12016-019-08775-4","volume":"59","author":"A Harish","year":"2020","unstructured":"Harish A, Schwartz SA (2020) Targeted Anti-IL-5 therapies and future therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic conditions. Clin Rev Allergy Immunol 59(2):231\u2013247. https:\/\/doi.org\/10.1007\/s12016-019-08775-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"5402_CR234","doi-asserted-by":"publisher","first-page":"106371","DOI":"10.1016\/j.nbd.2023.106371","volume":"190","author":"G Di Lazzaro","year":"2024","unstructured":"Di Lazzaro G, Picca A, Boldrini S, Bove F, Marzetti E, Petracca M et al (2024) Differential profiles of serum cytokines in Parkinson\u2019s disease according to disease duration. Neurobiol Dis 190:106371. https:\/\/doi.org\/10.1016\/j.nbd.2023.106371","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5402_CR235","doi-asserted-by":"publisher","first-page":"213","DOI":"10.22092\/ARI.2021.356478.1850","volume":"77","author":"S Hasan Kadhum Al-Huchaimi","year":"2022","unstructured":"Hasan Kadhum Al-Huchaimi S, Hameed Neamah Al-Kefaei G, Ahmed Alameedy B (2022) Effects of Toxoplasma gondii on levels of Interleukin-5 in Parkinson\u2019s patients. Arch Razi Inst 77(1):213\u2013220. https:\/\/doi.org\/10.22092\/ARI.2021.356478.1850","journal-title":"Arch Razi Inst"},{"key":"5402_CR236","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fnins.2015.00507","volume":"9","author":"DG Walker","year":"2015","unstructured":"Walker DG, Lue LF, Serrano G, Adler CH, Caviness JN, Sue LI et al (2015) Altered expression patterns of inflammation-Associated and Trophic molecules in Substantia Nigra and Striatum Brain samples from Parkinson\u2019s Disease, Incidental Lewy Body Disease and Normal Control cases. Front Neurosci 9:507. https:\/\/doi.org\/10.3389\/fnins.2015.00507","journal-title":"Front Neurosci"},{"issue":"2","key":"5402_CR237","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0304-3940(95)12153-6","volume":"201","author":"GE Ringheim","year":"1995","unstructured":"Ringheim GE (1995) Mitogenic effects of interleukin-5 on microglia. Neurosci Lett 201(2):131\u2013134. https:\/\/doi.org\/10.1016\/0304-3940(95)12153-6","journal-title":"Neurosci Lett"},{"issue":"6","key":"5402_CR238","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1023\/a:1010983119125","volume":"26","author":"SM Liva","year":"2001","unstructured":"Liva SM, de Vellis J (2001) IL-5 induces proliferation and activation of microglia via an unknown receptor. Neurochem Res 26(6):629\u2013637. https:\/\/doi.org\/10.1023\/a:1010983119125","journal-title":"Neurochem Res"},{"issue":"10","key":"5402_CR239","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1089\/dna.2019.4729","volume":"38","author":"J Chen","year":"2019","unstructured":"Chen J, Guan L, Tang L, Liu S, Zhou Y, Chen C et al (2019) T Helper 9 cells: a New Player in Immune-Related diseases. DNA Cell Biol 38(10):1040\u20131047. https:\/\/doi.org\/10.1089\/dna.2019.4729","journal-title":"DNA Cell Biol"},{"issue":"1","key":"5402_CR240","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4049\/jimmunol.1000356","volume":"185","author":"G Beriou","year":"2010","unstructured":"Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T et al (2010) TGF-beta induces IL-9 production from human Th17 cells. J Immunol 185(1):46\u201354. https:\/\/doi.org\/10.4049\/jimmunol.1000356","journal-title":"J Immunol"},{"issue":"19","key":"5402_CR241","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1089\/neu.2019.6963","volume":"37","author":"V Chaban","year":"2020","unstructured":"Chaban V, Clarke GJB, Skandsen T, Islam R, Einarsen CE, Vik A et al (2020) Systemic inflammation persists the First Year after mild traumatic brain Injury: results from the prospective Trondheim mild traumatic brain Injury Study. J Neurotrauma 37(19):2120\u20132130. https:\/\/doi.org\/10.1089\/neu.2019.6963","journal-title":"J Neurotrauma"},{"issue":"3","key":"5402_CR242","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","volume":"25","author":"M Saresella","year":"2011","unstructured":"Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Alberoni M et al (2011) Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease. Brain Behav Immun 25(3):539\u2013547. https:\/\/doi.org\/10.1016\/j.bbi.2010.12.004","journal-title":"Brain Behav Immun"},{"key":"5402_CR243","doi-asserted-by":"publisher","unstructured":"de la Monte SM, Tong M, Hapel AJ (2023) Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer\u2019s Disease. Biomedicines 11(9). https:\/\/doi.org\/10.3390\/biomedicines11092394","DOI":"10.3390\/biomedicines11092394"},{"issue":"8","key":"5402_CR244","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/eji.201041125","volume":"41","author":"H Li","year":"2011","unstructured":"Li H, Nourbakhsh B, Cullimore M, Zhang GX, Rostami A (2011) IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur J Immunol 41(8):2197\u20132206. https:\/\/doi.org\/10.1002\/eji.201041125","journal-title":"Eur J Immunol"},{"issue":"3","key":"5402_CR245","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4049\/jimmunol.1801113","volume":"204","author":"S Yoshimura","year":"2020","unstructured":"Yoshimura S, Thome R, Konno S, Mari ER, Rasouli J, Hwang D et al (2020) IL-9 controls central nervous system autoimmunity by suppressing GM-CSF production. J Immunol 204(3):531\u2013539. https:\/\/doi.org\/10.4049\/jimmunol.1801113","journal-title":"J Immunol"},{"issue":"1","key":"5402_CR246","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12974-020-01770-z","volume":"17","author":"G Donninelli","year":"2020","unstructured":"Donninelli G, Saraf-Sinik I, Mazziotti V, Capone A, Grasso MG, Battistini L et al (2020) Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain. J Neuroinflammation 17(1):149. https:\/\/doi.org\/10.1186\/s12974-020-01770-z","journal-title":"J Neuroinflammation"},{"issue":"31","key":"5402_CR247","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0812530106","volume":"106","author":"W Elyaman","year":"2009","unstructured":"Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J et al (2009) IL-9 induces differentiation of TH17 cells and enhances function of FoxP3\u2009+\u2009natural regulatory T cells. Proc Natl Acad Sci U S A 106(31):12885\u201312890. https:\/\/doi.org\/10.1073\/pnas.0812530106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5402_CR248","doi-asserted-by":"publisher","unstructured":"Picca A, Guerra F, Calvani R, Marini F, Biancolillo A, Landi G et al (2020) Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson\u2019s Disease: Results from the EXosomes in PArkiNson\u2019s Disease (EXPAND) Study. J Clin Med 9(2). https:\/\/doi.org\/10.3390\/jcm9020504","DOI":"10.3390\/jcm9020504"},{"key":"5402_CR249","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fneur.2019.00013","volume":"10","author":"E Storelli","year":"2019","unstructured":"Storelli E, Cassina N, Rasini E, Marino F, Cosentino M (2019) Do Th17 lymphocytes and IL-17 contribute to Parkinson\u2019s Disease? A systematic review of available evidence. Front Neurol 10:13. https:\/\/doi.org\/10.3389\/fneur.2019.00013","journal-title":"Front Neurol"},{"issue":"10","key":"5402_CR250","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1007\/s12035-016-0249-9","volume":"54","author":"Z Liu","year":"2017","unstructured":"Liu Z, Huang Y, Cao BB, Qiu YH, Peng YP (2017) Th17 cells induce dopaminergic neuronal death via LFA-1\/ICAM-1 Interaction in a mouse model of Parkinson\u2019s Disease. Mol Neurobiol 54(10):7762\u20137776. https:\/\/doi.org\/10.1007\/s12035-016-0249-9","journal-title":"Mol Neurobiol"},{"key":"5402_CR251","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","volume":"81","author":"Z Liu","year":"2019","unstructured":"Liu Z, Qiu AW, Huang Y, Yang Y, Chen JN, Gu TT et al (2019) IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson\u2019s disease. Brain Behav Immun 81:630\u2013645. https:\/\/doi.org\/10.1016\/j.bbi.2019.07.026","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5402_CR252","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer A, Marxreiter F, Krach F, Fadler T, Grosch J, Maroni M et al (2018) Th17 lymphocytes induce neuronal cell death in a human iPSC-Based model of Parkinson\u2019s Disease. Cell Stem Cell 23(1):123\u201331e6. https:\/\/doi.org\/10.1016\/j.stem.2018.06.015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"5402_CR253","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu L, Li R, Huang Y, Wang S (2023) The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther 8(1):402. https:\/\/doi.org\/10.1038\/s41392-023-01620-3","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5402_CR254","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in Health and Disease. Immunity 50(4):892\u2013906. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.021","journal-title":"Immunity"},{"key":"5402_CR255","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-015-0394-5","volume":"12","author":"J Sun","year":"2015","unstructured":"Sun J, Zhang S, Zhang X, Zhang X, Dong H, Qian Y (2015) IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation. J Neuroinflammation 12:165. https:\/\/doi.org\/10.1186\/s12974-015-0394-5","journal-title":"J Neuroinflammation"},{"key":"5402_CR256","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/ncomms2880","volume":"4","author":"S Liu","year":"2013","unstructured":"Liu S, Song X, Chrunyk BA, Shanker S, Hoth LR, Marr ES et al (2013) Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat Commun 4:1888. https:\/\/doi.org\/10.1038\/ncomms2880","journal-title":"Nat Commun"},{"issue":"4","key":"5402_CR257","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/BOR.0000000000000805","volume":"33","author":"N Yeremenko","year":"2021","unstructured":"Yeremenko N (2021) Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis. Curr Opin Rheumatol 33(4):333\u2013340. https:\/\/doi.org\/10.1097\/BOR.0000000000000805","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"5402_CR258","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13(10):1173\u20131175. https:\/\/doi.org\/10.1038\/nm1651","journal-title":"Nat Med"},{"key":"5402_CR259","doi-asserted-by":"publisher","first-page":"109571","DOI":"10.1016\/j.intimp.2022.109571","volume":"114","author":"YT Mohamed","year":"2023","unstructured":"Mohamed YT, Salama A, Rabie MA, Abd El Fattah MA (2023) Neuroprotective effect of secukinumab against rotenone induced Parkinson\u2019s disease in rat model: involvement of IL-17, HMGB-1\/TLR4 axis and BDNF\/TrKB cascade. Int Immunopharmacol 114:109571. https:\/\/doi.org\/10.1016\/j.intimp.2022.109571","journal-title":"Int Immunopharmacol"},{"issue":"6569","key":"5402_CR260","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.abf7266","volume":"374","author":"D Gate","year":"2021","unstructured":"Gate D, Tapp E, Leventhal O, Shahid M, Nonninger TJ, Yang AC et al (2021) CD4(+) T cells contribute to neurodegeneration in Lewy body dementia. Science 374(6569):868\u2013874. https:\/\/doi.org\/10.1126\/science.abf7266","journal-title":"Science"},{"issue":"1","key":"5402_CR261","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00702-023-02704-8","volume":"131","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li L, Ma X, Li Y, Gao B, Luo W (2024) The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson\u2019s disease. J Neural Transm (Vienna) 131(1):13\u201324. https:\/\/doi.org\/10.1007\/s00702-023-02704-8","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"5402_CR262","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JPD-191699","volume":"9","author":"HF Green","year":"2019","unstructured":"Green HF, Khosousi S, Svenningsson P, Plasma (2019) IL-6 and IL-17A correlate with severity of motor and non-motor symptoms in Parkinson\u2019s Disease. J Parkinsons Dis 9(4):705\u2013709. https:\/\/doi.org\/10.3233\/JPD-191699","journal-title":"J Parkinsons Dis"},{"key":"5402_CR263","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485\u2013517. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132710","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"5402_CR264","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","volume":"44","author":"P Kumar","year":"2016","unstructured":"Kumar P, Monin L, Castillo P, Elsegeiny W, Horne W, Eddens T et al (2016) Intestinal Interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Immunity 44(3):659\u2013671. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.007","journal-title":"Immunity"},{"issue":"3","key":"5402_CR265","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485\u2013498. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033","journal-title":"Cell"},{"issue":"5934","key":"5402_CR266","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser H, Sauer K, Brooks DG (2009) IL-21 is required to control chronic viral infection. Science 324(5934):1569\u20131572. https:\/\/doi.org\/10.1126\/science.1174182","journal-title":"Science"},{"issue":"5934","key":"5402_CR267","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi JS, Du M, Zajac AJ (2009) A vital role for interleukin-21 in the control of a chronic viral infection. Science 324(5934):1572\u20131576. https:\/\/doi.org\/10.1126\/science.1175194","journal-title":"Science"},{"issue":"5","key":"5402_CR268","doi-asserted-by":"publisher","first-page":"e1003362","DOI":"10.1371\/journal.ppat.1003362","volume":"9","author":"I Schmitz","year":"2013","unstructured":"Schmitz I, Schneider C, Frohlich A, Frebel H, Christ D, Leonard WJ et al (2013) IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog 9(5):e1003362. https:\/\/doi.org\/10.1371\/journal.ppat.1003362","journal-title":"PLoS Pathog"},{"key":"5402_CR269","doi-asserted-by":"publisher","first-page":"1269354","DOI":"10.3389\/fnins.2023.1269354","volume":"17","author":"Z Hu","year":"2023","unstructured":"Hu Z, Zuo C, Mao C, Shi C, Xu Y (2023) Peripheral immune markers and amyotrophic lateral sclerosis: a mendelian randomization study. Front Neurosci 17:1269354. https:\/\/doi.org\/10.3389\/fnins.2023.1269354","journal-title":"Front Neurosci"},{"issue":"6","key":"5402_CR270","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00018-022-04347-6","volume":"79","author":"S Agrawal","year":"2022","unstructured":"Agrawal S, Baulch JE, Madan S, Salah S, Cheeks SN, Krattli RP Jr. et al (2022) Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer\u2019s disease neuropathology. Cell Mol Life Sci 79(6):331. https:\/\/doi.org\/10.1007\/s00018-022-04347-6","journal-title":"Cell Mol Life Sci"},{"issue":"35","key":"5402_CR271","doi-asserted-by":"publisher","first-page":"12378","DOI":"10.1074\/jbc.RA120.013927","volume":"295","author":"S Mossner","year":"2020","unstructured":"Mossner S, Kuchner M, Fazel Modares N, Knebel B, Al-Hasani H, Floss DM et al (2020) Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130. J Biol Chem 295(35):12378\u201312397. https:\/\/doi.org\/10.1074\/jbc.RA120.013927","journal-title":"J Biol Chem"},{"issue":"1","key":"5402_CR272","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13(1):21\u201338. https:\/\/doi.org\/10.1038\/nrd4176","journal-title":"Nat Rev Drug Discov"},{"issue":"31","key":"5402_CR273","doi-asserted-by":"publisher","first-page":"12768","DOI":"10.1073\/pnas.1300318110","volume":"110","author":"CL Zindl","year":"2013","unstructured":"Zindl CL, Lai JF, Lee YK, Maynard CL, Harbour SN, Ouyang W et al (2013) IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci U S A 110(31):12768\u201312773. https:\/\/doi.org\/10.1073\/pnas.1300318110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7128","key":"5402_CR274","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J et al (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445(7128):648\u2013651. https:\/\/doi.org\/10.1038\/nature05505","journal-title":"Nature"},{"issue":"2","key":"5402_CR275","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3341\/kjo.2017.0068","volume":"32","author":"CH Yoon","year":"2018","unstructured":"Yoon CH, Lee D, Jeong HJ, Ryu JS, Kim MK (2018) Distribution of Interleukin-22-secreting Immune cells in Conjunctival Associated Lymphoid tissue. Korean J Ophthalmol 32(2):147\u2013153. https:\/\/doi.org\/10.3341\/kjo.2017.0068","journal-title":"Korean J Ophthalmol"},{"key":"5402_CR276","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-015-0335-3","volume":"12","author":"G Perriard","year":"2015","unstructured":"Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M et al (2015) Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation 12:119. https:\/\/doi.org\/10.1186\/s12974-015-0335-3","journal-title":"J Neuroinflammation"},{"key":"5402_CR277","doi-asserted-by":"publisher","first-page":"958022","DOI":"10.3389\/fphar.2022.958022","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Wang J, Yang H, Sun Y, Chen B, Liu Y et al (2022) Interleukin 22 and its association with neurodegenerative disease activity. Front Pharmacol 13:958022. https:\/\/doi.org\/10.3389\/fphar.2022.958022","journal-title":"Front Pharmacol"},{"issue":"6","key":"5402_CR278","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s11064-021-03293-2","volume":"46","author":"X Liu","year":"2021","unstructured":"Liu X, Liu S, Tang Y, Pu Z, Xiao H, Gao J et al (2021) Intragastric Administration of Casein Leads to Nigrostriatal Disease progressed accompanied with persistent nigrostriatal-intestinal inflammation Activited and Intestinal Microbiota-Metabolic disorders Induced in MPTP Mouse Model of Parkinson\u2019s Disease. Neurochem Res 46(6):1514\u20131539. https:\/\/doi.org\/10.1007\/s11064-021-03293-2","journal-title":"Neurochem Res"},{"issue":"6","key":"5402_CR279","first-page":"567","volume":"30","author":"Y Huang","year":"2014","unstructured":"Huang Y, Liu Z, Wang XQ, Qiu YH, Peng YP (2014) A dysfunction of CD4\u2009+\u2009T lymphocytes in peripheral immune system of Parkinson\u2019s disease model mice. Zhongguo Ying Yong Sheng Li Xue Za Zhi 30(6):567\u2013576","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"10","key":"5402_CR280","doi-asserted-by":"publisher","first-page":"e75786","DOI":"10.1371\/journal.pone.0075786","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Ke KF, Liu Z, Qiu YH, Peng YP (2013) Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer\u2019s disease model rats. PLoS ONE 8(10):e75786. https:\/\/doi.org\/10.1371\/journal.pone.0075786","journal-title":"PLoS ONE"},{"key":"5402_CR281","doi-asserted-by":"publisher","first-page":"217doi","DOI":"10.3389\/fimmu.2018.00217","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath G, Park C, Pitt D (2018) The role of astrocytes in multiple sclerosis. Front Immunol 9:217doi. https:\/\/doi.org\/10.3389\/fimmu.2018.00217","journal-title":"Front Immunol"},{"key":"5402_CR282","doi-asserted-by":"publisher","unstructured":"Lee D, Jo H, Go C, Jang Y, Chu N, Bae S et al (2022) The roles of IL-22 and its receptor in the regulation of inflammatory responses in the brain. Int J Mol Sci 23(2). https:\/\/doi.org\/10.3390\/ijms23020757","DOI":"10.3390\/ijms23020757"},{"key":"5402_CR283","doi-asserted-by":"publisher","first-page":"155280","DOI":"10.1016\/j.phymed.2023.155280","volume":"124","author":"Z Gao","year":"2024","unstructured":"Gao Z, Tan H, Song X, Zhuang T, Kong R, Wang Y et al (2024) Troxerutin dampened hypothalamic neuroinflammation via microglial IL-22\/IL-22R1\/IRF3 activation in dihydrotestosterone-induced polycystic ovary syndrome rats. Phytomedicine 124:155280. https:\/\/doi.org\/10.1016\/j.phymed.2023.155280","journal-title":"Phytomedicine"},{"key":"5402_CR284","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2022.10.023","volume":"108","author":"J Li","year":"2023","unstructured":"Li J, Zhao J, Chen L, Gao H, Zhang J, Wang D et al (2023) Alpha-synuclein induces Th17 differentiation and impairs the function and stability of Tregs by promoting RORC transcription in Parkinson\u2019s disease. Brain Behav Immun 108:32\u201344. https:\/\/doi.org\/10.1016\/j.bbi.2022.10.023","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5402_CR285","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","volume":"7","author":"AD Thome","year":"2021","unstructured":"Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR et al (2021) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease. NPJ Parkinsons Dis 7(1):41. https:\/\/doi.org\/10.1038\/s41531-021-00188-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"5402_CR286","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0507296","volume":"82","author":"AD Reynolds","year":"2007","unstructured":"Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL (2007) Neuroprotective activities of CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells in an animal model of Parkinson\u2019s disease. J Leukoc Biol 82(5):1083\u20131094. https:\/\/doi.org\/10.1189\/jlb.0507296","journal-title":"J Leukoc Biol"},{"issue":"6","key":"5402_CR287","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.4049\/jimmunol.0803330","volume":"182","author":"J Liu","year":"2009","unstructured":"Liu J, Gong N, Huang X, Reynolds AD, Mosley RL, Gendelman HE (2009) Neuromodulatory activities of CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J Immunol 182(6):3855\u20133865. https:\/\/doi.org\/10.4049\/jimmunol.0803330","journal-title":"J Immunol"},{"issue":"7","key":"5402_CR288","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","volume":"182","author":"AD Reynolds","year":"2009","unstructured":"Reynolds AD, Stone DK, Mosley RL, Gendelman HE (2009) Nitrated alpha-synuclein-induced alterations in microglial immunity are regulated by CD4\u2009+\u2009T cell subsets. J Immunol 182(7):4137\u20134149. https:\/\/doi.org\/10.4049\/jimmunol.0803982","journal-title":"J Immunol"},{"issue":"2","key":"5402_CR289","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S et al (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15(2):192\u2013199. https:\/\/doi.org\/10.1038\/nm.1927","journal-title":"Nat Med"},{"issue":"1","key":"5402_CR290","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-020-01776-7","volume":"17","author":"J Rostami","year":"2020","unstructured":"Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergstrom J, Essand M et al (2020) Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson\u2019s disease brain. J Neuroinflammation 17(1):119. https:\/\/doi.org\/10.1186\/s12974-020-01776-7","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5402_CR291","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1159\/000464388","volume":"41","author":"Y Huang","year":"2017","unstructured":"Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP (2017) Treg Cells Protect Dopaminergic Neurons against MPP\u2009+\u2009neurotoxicity via CD47-SIRPA Interaction. Cell Physiol Biochem 41(3):1240\u20131254. https:\/\/doi.org\/10.1159\/000464388","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"5402_CR292","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","volume":"15","author":"Y Huang","year":"2020","unstructured":"Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP (2020) Treg Cells Attenuate Neuroinflammation and protect neurons in a mouse model of Parkinson\u2019s Disease. J Neuroimmune Pharmacol 15(2):224\u2013237. https:\/\/doi.org\/10.1007\/s11481-019-09888-5","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"5402_CR293","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101. https:\/\/doi.org\/10.1080\/10408398.2017.1358139","journal-title":"Crit Rev Food Sci Nutr"},{"key":"5402_CR294","doi-asserted-by":"publisher","unstructured":"Porro C, Cianciulli A, Panaro MA (2020) The Regulatory Role of IL-10 in neurodegenerative diseases. Biomolecules 10(7). https:\/\/doi.org\/10.3390\/biom10071017","DOI":"10.3390\/biom10071017"},{"key":"5402_CR295","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A (2018) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol 327:77\u201382. https:\/\/doi.org\/10.1016\/j.cellimm.2018.02.011","journal-title":"Cell Immunol"},{"key":"5402_CR296","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neulet.2018.07.027","volume":"683","author":"D Li","year":"2018","unstructured":"Li D, Song X, Huang H, Huang H, Ye Z (2018) Association of Parkinson\u2019s disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-alpha. Neurosci Lett 683:181\u2013184. https:\/\/doi.org\/10.1016\/j.neulet.2018.07.027","journal-title":"Neurosci Lett"},{"issue":"3","key":"5402_CR297","doi-asserted-by":"publisher","first-page":"484","DOI":"10.19852\/j.cnki.jtcm.20230214.005","volume":"43","author":"WU Haiyang","year":"2023","unstructured":"Haiyang WU, Ying W, Wei H, Huihui LI, Haisheng JI, Xiuxiu L (2023) Protective effect of Tongdu Tiaoshen acupuncture combined with xiaoxuming decoction on dopaminergic neurons in Parkinson\u2019s disease model. J Tradit Chin Med 43(3):484\u2013493. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.20230214.005","journal-title":"J Tradit Chin Med"},{"issue":"7","key":"5402_CR298","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s11011-023-01266-8","volume":"38","author":"T Pan","year":"2023","unstructured":"Pan T, Xiao Q, Fan HJ, Xu L, Qin SC, Yang LX et al (2023) Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation. Metab Brain Dis 38(7):2211\u20132222. https:\/\/doi.org\/10.1007\/s11011-023-01266-8","journal-title":"Metab Brain Dis"},{"issue":"8","key":"5402_CR299","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/mt.2008.113","volume":"16","author":"LC Johnston","year":"2008","unstructured":"Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, Guschin D et al (2008) Human interleukin-10 gene transfer is protective in a rat model of Parkinson\u2019s disease. Mol Ther 16(8):1392\u20131399. https:\/\/doi.org\/10.1038\/mt.2008.113","journal-title":"Mol Ther"},{"issue":"1","key":"5402_CR300","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s1734-1140(13)70962-9","volume":"65","author":"J Schwenkgrub","year":"2013","unstructured":"Schwenkgrub J, Joniec-Maciejak I, Sznejder-Pacholek A, Wawer A, Ciesielska A, Bankiewicz K et al (2013) Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson\u2019s disease. Pharmacol Rep 65(1):44\u201349. https:\/\/doi.org\/10.1016\/s1734-1140(13)70962-9","journal-title":"Pharmacol Rep"},{"issue":"4","key":"5402_CR301","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.pharep.2014.03.008","volume":"66","author":"I Joniec-Maciejak","year":"2014","unstructured":"Joniec-Maciejak I, Ciesielska A, Wawer A, Sznejder-Pacholek A, Schwenkgrub J, Cudna A et al (2014) The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson\u2019s disease. Pharmacol Rep 66(4):660\u2013669. https:\/\/doi.org\/10.1016\/j.pharep.2014.03.008","journal-title":"Pharmacol Rep"},{"key":"5402_CR302","doi-asserted-by":"publisher","unstructured":"Zhu Y, Chen X, Liu Z, Peng YP, Qiu YH (2015) Interleukin-10 protection against Lipopolysaccharide-Induced neuro-inflammation and neurotoxicity in ventral mesencephalic cultures. Int J Mol Sci 17(1). https:\/\/doi.org\/10.3390\/ijms17010025","DOI":"10.3390\/ijms17010025"},{"key":"5402_CR303","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.intimp.2017.07.017","volume":"50","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Liu Z, Peng YP, Qiu YH (2017) Interleukin-10 inhibits neuroinflammation-mediated apoptosis of ventral mesencephalic neurons via JAK-STAT3 pathway. Int Immunopharmacol 50:353\u2013360. https:\/\/doi.org\/10.1016\/j.intimp.2017.07.017","journal-title":"Int Immunopharmacol"},{"key":"5402_CR304","doi-asserted-by":"publisher","unstructured":"Gao Y, Tu D, Yang R, Chu CH, Hong JS, Gao HM, Through Reducing ROS, Production (2020) IL-10 suppresses Caspase-1-Dependent IL-1beta maturation, thereby preventing chronic neuroinflammation and neurodegeneration. Int J Mol Sci 21(2). https:\/\/doi.org\/10.3390\/ijms21020465","DOI":"10.3390\/ijms21020465"},{"key":"5402_CR305","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-015-0258-z","volume":"12","author":"S Yang","year":"2015","unstructured":"Yang S, Gao L, Lu F, Wang B, Gao F, Zhu G et al (2015) Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death. J Neuroinflammation 12:33. https:\/\/doi.org\/10.1186\/s12974-015-0258-z","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5402_CR306","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-021-00169-8","volume":"7","author":"SG Cockey","year":"2021","unstructured":"Cockey SG, McFarland KN, Koller EJ, Brooks MMT, De La Cruz G, Cruz E (2021) Il-10 signaling reduces survival in mouse models of synucleinopathy. NPJ Parkinsons Dis 7(1):30. https:\/\/doi.org\/10.1038\/s41531-021-00169-8","journal-title":"NPJ Parkinsons Dis"},{"issue":"7169","key":"5402_CR307","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566\u2013569. https:\/\/doi.org\/10.1038\/nature06306","journal-title":"Nature"},{"issue":"7492","key":"5402_CR308","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O\u2019Connor RA, Stervbo U, Hilgenberg E et al (2014) IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507(7492):366\u2013370. https:\/\/doi.org\/10.1038\/nature12979","journal-title":"Nature"},{"issue":"7","key":"5402_CR309","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","volume":"17","author":"LC Su","year":"2018","unstructured":"Su LC, Liu XY, Huang AF, Xu WD (2018) Emerging role of IL-35 in inflammatory autoimmune diseases. Autoimmun Rev 17(7):665\u2013673. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.017","journal-title":"Autoimmun Rev"},{"issue":"12","key":"5402_CR310","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1523\/JNEUROSCI.1815-18.2019","volume":"39","author":"SS Duffy","year":"2019","unstructured":"Duffy SS, Keating BA, Perera CJ, Lees JG, Tonkin RS, Makker PGS et al (2019) Regulatory T cells and their derived cytokine, Interleukin-35, reduce Pain in Experimental Autoimmune Encephalomyelitis. J Neurosci 39(12):2326\u20132346. https:\/\/doi.org\/10.1523\/JNEUROSCI.1815-18.2019","journal-title":"J Neurosci"},{"key":"5402_CR311","doi-asserted-by":"publisher","first-page":"624304","DOI":"10.3389\/fnagi.2020.624304","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Duan J, Mo J, Xiao H, Huang Y, Chen W et al (2020) Mild cognitive impairment patients have higher Regulatory T-Cell proportions compared with Alzheimer\u2019s Disease-related dementia patients. Front Aging Neurosci 12:624304. https:\/\/doi.org\/10.3389\/fnagi.2020.624304","journal-title":"Front Aging Neurosci"},{"key":"5402_CR312","doi-asserted-by":"publisher","first-page":"109109","DOI":"10.1016\/j.exer.2022.109109","volume":"220","author":"B Lin","year":"2022","unstructured":"Lin B, Li Y, Jiang N, Huang S, Su W, Zhuo Y (2022) Interleukin-35 suppresses pyroptosis and protects against neuronal death in retinal ischaemia\/reperfusion injury. Exp Eye Res 220:109109. https:\/\/doi.org\/10.1016\/j.exer.2022.109109","journal-title":"Exp Eye Res"},{"issue":"20","key":"5402_CR313","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.21037\/atm-21-4879","volume":"9","author":"F Luo","year":"2021","unstructured":"Luo F, Huang Y, Li Y, Zhao X, Xie Y, Zhang Q et al (2021) A narrative review of the relationship between TGF-beta signaling and gynecological malignant tumor. Ann Transl Med 9(20):1601. https:\/\/doi.org\/10.21037\/atm-21-4879","journal-title":"Ann Transl Med"},{"issue":"9","key":"5402_CR314","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1634\/stemcells.2005-0514","volume":"24","author":"E Roussa","year":"2006","unstructured":"Roussa E, Wiehle M, Dunker N, Becker-Katins S, Oehlke O, Krieglstein K (2006) Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon. Stem Cells 24(9):2120\u20132129. https:\/\/doi.org\/10.1634\/stemcells.2005-0514","journal-title":"Stem Cells"},{"issue":"17","key":"5402_CR315","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","volume":"37","author":"I Tesseur","year":"2017","unstructured":"Tesseur I, Nguyen A, Chang B, Li L, Woodling NS, Wyss-Coray T et al (2017) Deficiency in neuronal TGF-beta signaling leads to Nigrostriatal Degeneration and activation of TGF-beta signaling protects against MPTP Neurotoxicity in mice. J Neurosci 37(17):4584\u20134592. https:\/\/doi.org\/10.1523\/JNEUROSCI.2952-16.2017","journal-title":"J Neurosci"},{"issue":"1","key":"5402_CR316","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cell.2010.06.010","volume":"142","author":"JJ Yi","year":"2010","unstructured":"Yi JJ, Barnes AP, Hand R, Polleux F, Ehlers MD (2010) TGF-beta signaling specifies axons during brain development. Cell 142(1):144\u2013157. https:\/\/doi.org\/10.1016\/j.cell.2010.06.010","journal-title":"Cell"},{"issue":"2","key":"5402_CR317","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.nbd.2004.03.006","volume":"16","author":"E Roussa","year":"2004","unstructured":"Roussa E, Farkas LM, Krieglstein K (2004) TGF-beta promotes survival on mesencephalic dopaminergic neurons in cooperation with shh and FGF-8. Neurobiol Dis 16(2):300\u2013310. https:\/\/doi.org\/10.1016\/j.nbd.2004.03.006","journal-title":"Neurobiol Dis"},{"issue":"11","key":"5402_CR318","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/80598","volume":"3","author":"K Krieglstein","year":"2000","unstructured":"Krieglstein K, Richter S, Farkas L, Schuster N, Dunker N, Oppenheim RW et al (2000) Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat Neurosci 3(11):1085\u20131090. https:\/\/doi.org\/10.1038\/80598","journal-title":"Nat Neurosci"},{"issue":"6","key":"5402_CR319","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/s0896-6273(03)00766-9","volume":"40","author":"TC Brionne","year":"2003","unstructured":"Brionne TC, Tesseur I, Masliah E, Wyss-Coray T (2003) Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40(6):1133\u20131145. https:\/\/doi.org\/10.1016\/s0896-6273(03)00766-9","journal-title":"Neuron"},{"issue":"1","key":"5402_CR320","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jnc.13111","volume":"134","author":"X Zhou","year":"2015","unstructured":"Zhou X, Zoller T, Krieglstein K, Spittau B (2015) TGFbeta1 inhibits IFNgamma-mediated microglia activation and protects mDA neurons from IFNgamma-driven neurotoxicity. J Neurochem 134(1):125\u2013134. https:\/\/doi.org\/10.1111\/jnc.13111","journal-title":"J Neurochem"},{"key":"5402_CR321","doi-asserted-by":"publisher","unstructured":"Luo J (2022) TGF-beta as a key modulator of astrocyte reactivity: Disease Relevance and therapeutic implications. Biomedicines 10(5). https:\/\/doi.org\/10.3390\/biomedicines10051206","DOI":"10.3390\/biomedicines10051206"},{"key":"5402_CR322","doi-asserted-by":"publisher","first-page":"1111705","DOI":"10.3389\/fcell.2023.1111705","volume":"11","author":"S Sibuea","year":"2023","unstructured":"Sibuea S, Ho JK, Pouton CW, Haynes JM (2023) TGFbeta3, dibutyryl cAMP and a notch inhibitor modulate phenotype late in stem cell-derived dopaminergic neuron maturation. Front Cell Dev Biol 11:1111705. https:\/\/doi.org\/10.3389\/fcell.2023.1111705","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"5402_CR323","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3233\/JAD-200885","volume":"78","author":"EM Khedr","year":"2020","unstructured":"Khedr EM, Gomaa AMS, Ahmed OG, Sayed HMM, Gamea A, Cognitive Impairment (2020) P300, and transforming growth factor beta1 in different forms of Dementia. J Alzheimers Dis 78(2):837\u2013845. https:\/\/doi.org\/10.3233\/JAD-200885","journal-title":"J Alzheimers Dis"},{"key":"5402_CR324","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y (2018) Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s Disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and Meta-analysis. Front Immunol 9:2122. https:\/\/doi.org\/10.3389\/fimmu.2018.02122","journal-title":"Front Immunol"},{"issue":"14","key":"5402_CR325","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283(14):9089\u20139100. https:\/\/doi.org\/10.1074\/jbc.M710012200","journal-title":"J Biol Chem"},{"issue":"2","key":"5402_CR326","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/jnc.14710","volume":"150","author":"LP Diniz","year":"2019","unstructured":"Diniz LP, Matias I, Araujo APB, Garcia MN, Barros-Aragao FGQ, Alves-Leon SV et al (2019) Alpha-synuclein oligomers enhance astrocyte-induced synapse formation through TGF-beta1 signaling in a Parkinson\u2019s disease model. J Neurochem 150(2):138\u2013157. https:\/\/doi.org\/10.1111\/jnc.14710","journal-title":"J Neurochem"},{"key":"5402_CR327","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2015.08.006","volume":"51","author":"Z Liu","year":"2016","unstructured":"Liu Z, Chen HQ, Huang Y, Qiu YH, Peng YP (2016) Transforming growth factor-beta1 acts via TbetaR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss. Brain Behav Immun 51:131\u2013143. https:\/\/doi.org\/10.1016\/j.bbi.2015.08.006","journal-title":"Brain Behav Immun"},{"issue":"3","key":"5402_CR328","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","volume":"12","author":"X Chen","year":"2017","unstructured":"Chen X, Liu Z, Cao BB, Qiu YH, Peng YP (2017) TGF-beta1 neuroprotection via inhibition of Microglial activation in a rat model of Parkinson\u2019s Disease. J Neuroimmune Pharmacol 12(3):433\u2013446. https:\/\/doi.org\/10.1007\/s11481-017-9732-y","journal-title":"J Neuroimmune Pharmacol"},{"issue":"12","key":"5402_CR329","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/hipo.22159","volume":"23","author":"A Martinez-Canabal","year":"2013","unstructured":"Martinez-Canabal A, Wheeler AL, Sarkis D, Lerch JP, Lu WY, Buckwalter MS et al (2013) Chronic over-expression of TGFbeta1 alters hippocampal structure and causes learning deficits. Hippocampus 23(12):1198\u20131211. https:\/\/doi.org\/10.1002\/hipo.22159","journal-title":"Hippocampus"},{"issue":"1","key":"5402_CR330","doi-asserted-by":"publisher","first-page":"e0167211","DOI":"10.1371\/journal.pone.0167211","volume":"12","author":"S Stayte","year":"2017","unstructured":"Stayte S, Rentsch P, Troscher AR, Bamberger M, Li KM, Vissel B (2017) Activin A inhibits MPTP and LPS-Induced increases in inflammatory cell populations and loss of dopamine neurons in the mouse midbrain in vivo. PLoS ONE 12(1):e0167211. https:\/\/doi.org\/10.1371\/journal.pone.0167211","journal-title":"PLoS ONE"},{"issue":"5","key":"5402_CR331","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3892\/etm.2021.10705","volume":"22","author":"WW Jiang","year":"2021","unstructured":"Jiang WW, Zhang ZZ, He PP, Jiang LP, Chen JZ, Zhang XT et al (2021) Emerging roles of growth differentiation factor-15 in brain disorders (review). Exp Ther Med 22(5):1270. https:\/\/doi.org\/10.3892\/etm.2021.10705","journal-title":"Exp Ther Med"},{"issue":"8","key":"5402_CR332","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.4103\/1673-5374.274327","volume":"15","author":"SR Goulding","year":"2020","unstructured":"Goulding SR, Sullivan AM, O\u2019Keeffe GW, Collins LM (2020) The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson\u2019s disease. Neural Regen Res 15(8):1432\u20131436. https:\/\/doi.org\/10.4103\/1673-5374.274327","journal-title":"Neural Regen Res"},{"key":"5402_CR333","doi-asserted-by":"publisher","first-page":"572205","DOI":"10.3389\/fneur.2020.572205","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, Jin T, Zheng C, Ma D, Zhang Y (2020) Imbalance of circulating Tfh\/Tfr cells in patients with Parkinson\u2019s Disease. Front Neurol 11:572205. https:\/\/doi.org\/10.3389\/fneur.2020.572205","journal-title":"Front Neurol"},{"key":"5402_CR334","doi-asserted-by":"publisher","unstructured":"Li R, Tropea TF, Baratta LR, Zuroff L, Diaz-Ortiz ME, Zhang B et al (2022) Abnormal B-Cell and tfh-cell profiles in patients with Parkinson Disease: a cross-sectional study. Neurol Neuroimmunol Neuroinflamm 9(2). https:\/\/doi.org\/10.1212\/NXI.0000000000001125","DOI":"10.1212\/NXI.0000000000001125"},{"issue":"8","key":"5402_CR335","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","volume":"16","author":"N Tambasco","year":"2018","unstructured":"Tambasco N, Romoli M, Calabresi P (2018) Levodopa in Parkinson\u2019s Disease: current status and future developments. Curr Neuropharmacol 16(8):1239\u20131252. https:\/\/doi.org\/10.2174\/1570159X15666170510143821","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"5402_CR336","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12974-016-0710-8","volume":"13","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Agusti A, Cabrera-Pastor A, Taoro-Gonzalez L et al (2016) Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. J Neuroinflammation 13(1):245. https:\/\/doi.org\/10.1186\/s12974-016-0710-8","journal-title":"J Neuroinflammation"},{"issue":"10","key":"5402_CR337","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.18632\/aging.203009","volume":"13","author":"JJ Xu","year":"2021","unstructured":"Xu JJ, Guo S, Xue R, Xiao L, Kou JN, Liu YQ et al (2021) Adalimumab ameliorates memory impairments and neuroinflammation in chronic cerebral hypoperfusion rats. Aging 13(10):14001\u201314014. https:\/\/doi.org\/10.18632\/aging.203009","journal-title":"Aging"},{"issue":"9","key":"5402_CR338","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40265-014-0239-z","volume":"74","author":"S Dhillon","year":"2014","unstructured":"Dhillon S (2014) Certolizumab pegol: a review of its use in patients with axial spondyloarthritis or psoriatic arthritis. Drugs 74(9):999\u20131016. https:\/\/doi.org\/10.1007\/s40265-014-0239-z","journal-title":"Drugs"},{"issue":"7","key":"5402_CR339","doi-asserted-by":"publisher","first-page":"970","DOI":"10.2174\/1389201022666210810141139","volume":"23","author":"V Pavitrakar","year":"2022","unstructured":"Pavitrakar V, Mody R, Ravindran S (2022) Amelioration of cisplatin-induced renal inflammation by recombinant human golimumab in mice. Curr Pharm Biotechnol 23(7):970\u2013977. https:\/\/doi.org\/10.2174\/1389201022666210810141139","journal-title":"Curr Pharm Biotechnol"},{"issue":"8","key":"5402_CR340","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","volume":"75","author":"I Peter","year":"2018","unstructured":"Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N et al (2018) Anti-tumor Necrosis factor therapy and incidence of Parkinson Disease among patients with inflammatory bowel disease. JAMA Neurol 75(8):939\u2013946. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0605","journal-title":"JAMA Neurol"},{"issue":"5","key":"5402_CR341","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/0091270004273321","volume":"45","author":"H Zhou","year":"2005","unstructured":"Zhou H (2005) Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. J Clin Pharmacol 45(5):490\u2013497. https:\/\/doi.org\/10.1177\/0091270004273321","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"5402_CR342","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/imt-2017-0155","volume":"10","author":"S Zhao","year":"2018","unstructured":"Zhao S, Mysler E, Moots RJ (2018) Etanercept for the treatment of rheumatoid arthritis. Immunotherapy 10(6):433\u2013445. https:\/\/doi.org\/10.2217\/imt-2017-0155","journal-title":"Immunotherapy"},{"issue":"8","key":"5402_CR343","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2165\/00002018-200629080-00004","volume":"29","author":"JL Sanchez Carazo","year":"2006","unstructured":"Sanchez Carazo JL, Mahiques Santos L, Oliver Martinez V (2006) Safety of etanercept in psoriasis: a critical review. Drug Saf 29(8):675\u2013685. https:\/\/doi.org\/10.2165\/00002018-200629080-00004","journal-title":"Drug Saf"},{"issue":"4","key":"5402_CR344","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ad.2014.09.004","volume":"106","author":"L Puig","year":"2015","unstructured":"Puig L, Lopez-Ferrer A, Laiz A (2015) Etanercept in the treatment of psoriatic arthritis. Actas Dermosifiliogr 106(4):252\u2013259. https:\/\/doi.org\/10.1016\/j.ad.2014.09.004","journal-title":"Actas Dermosifiliogr"},{"key":"5402_CR345","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2147\/PPA.S33109","volume":"7","author":"JM Senabre-Gallego","year":"2013","unstructured":"Senabre-Gallego JM, Santos-Ramirez C, Santos-Soler G, Salas-Heredia E, Sanchez-Barrioluengo M, Barber X et al (2013) Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis. Patient Prefer Adherence 7:961\u2013972. https:\/\/doi.org\/10.2147\/PPA.S33109","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"5402_CR346","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12868-019-0529-1","volume":"20","author":"SH Shin","year":"2019","unstructured":"Shin SH, Kim EK, Lee KY, Kim HS (2019) TNF-alpha antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats. BMC Neurosci 20(1):45. https:\/\/doi.org\/10.1186\/s12868-019-0529-1","journal-title":"BMC Neurosci"},{"issue":"4","key":"5402_CR347","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/00063030-200216040-00005","volume":"16","author":"RS Cvetkovic","year":"2002","unstructured":"Cvetkovic RS, Keating G, Anakinra (2002) BioDrugs 16(4):303\u2013311 discussion 13\u2009\u2013\u20094. https:\/\/doi.org\/10.2165\/00063030-200216040-00005","journal-title":"BioDrugs"},{"issue":"15","key":"5402_CR348","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B et al (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356(15):1517\u20131526. https:\/\/doi.org\/10.1056\/NEJMoa065213","journal-title":"N Engl J Med"},{"issue":"2","key":"5402_CR349","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/MJT.0000000000001603","volume":"30","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Dima L, Willett KC (2023) Anakinra-An Interleukin-1 receptor antagonist for COVID-19. Am J Ther 30(2):e108\u2013e16. https:\/\/doi.org\/10.1097\/MJT.0000000000001603","journal-title":"Am J Ther"},{"issue":"3","key":"5402_CR350","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/23969873231185208","volume":"8","author":"AR Parry-Jones","year":"2023","unstructured":"Parry-Jones AR, Stocking K, MacLeod MJ, Clarke B, Werring DJ, Muir KW et al (2023) Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the cytokine IL-1 in ICH (BLOC-ICH). Eur Stroke J 8(3):819\u2013827. https:\/\/doi.org\/10.1177\/23969873231185208","journal-title":"Eur Stroke J"},{"issue":"8","key":"5402_CR351","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.41699","volume":"73","author":"KG Saag","year":"2021","unstructured":"Saag KG, Khanna PP, Keenan RT, Ohlman S, Osterling Koskinen L, Sparve E et al (2021) A randomized, phase II study evaluating the efficacy and safety of Anakinra in the treatment of gout flares. Arthritis Rheumatol 73(8):1533\u20131542. https:\/\/doi.org\/10.1002\/art.41699","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"5402_CR352","doi-asserted-by":"publisher","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","volume":"9","author":"A Abbate","year":"2020","unstructured":"Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D et al (2020) Interleukin-1 blockade inhibits the Acute Inflammatory response in patients with ST-Segment-Elevation myocardial infarction. J Am Heart Assoc 9(5):e014941. https:\/\/doi.org\/10.1161\/JAHA.119.014941","journal-title":"J Am Heart Assoc"},{"key":"5402_CR353","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008) Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflammation 5:8. https:\/\/doi.org\/10.1186\/1742-2094-5-8","journal-title":"J Neuroinflammation"},{"key":"5402_CR354","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/ITT.S259126","volume":"10","author":"F Atzeni","year":"2021","unstructured":"Atzeni F, Carriero A, Boccassini L, D\u2019Angelo S, Anti (2021) -IL-17 agents in the treatment of Axial Spondyloarthritis. Immunotargets Ther 10:141\u2013153. https:\/\/doi.org\/10.2147\/ITT.S259126","journal-title":"Immunotargets Ther"},{"issue":"5","key":"5402_CR355","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1517\/14712598.2016.1167183","volume":"16","author":"J Braun","year":"2016","unstructured":"Braun J, Baraliakos X, Kiltz U (2016) Secukinumab (AIN457) in the treatment of ankylosing spondylitis. Expert Opin Biol Ther 16(5):711\u2013722. https:\/\/doi.org\/10.1517\/14712598.2016.1167183","journal-title":"Expert Opin Biol Ther"},{"issue":"7970","key":"5402_CR356","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"TY Park","year":"2023","unstructured":"Park TY, Jeon J, Lee N, Kim J, Song B, Kim JH et al (2023) Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson\u2019s disease. Nature 619(7970):606\u2013615. https:\/\/doi.org\/10.1038\/s41586-023-06300-4","journal-title":"Nature"},{"issue":"8","key":"5402_CR357","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/jir.2014.0149","volume":"35","author":"P Bhattacharya","year":"2015","unstructured":"Bhattacharya P, Budnick I, Singh M, Thiruppathi M, Alharshawi K, Elshabrawy H et al (2015) Dual role of GM-CSF as a pro-inflammatory and a Regulatory Cytokine: implications for Immune Therapy. J Interferon Cytokine Res 35(8):585\u2013599. https:\/\/doi.org\/10.1089\/jir.2014.0149","journal-title":"J Interferon Cytokine Res"},{"key":"5402_CR358","doi-asserted-by":"publisher","first-page":"10doi","DOI":"10.1038\/s41531-017-0013-5","volume":"3","author":"HE Gendelman","year":"2017","unstructured":"Gendelman HE, Zhang Y, Santamaria P, Olson KE, Schutt CR, Bhatti D et al (2017) Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson\u2019s disease trial. NPJ Parkinsons Dis 3:10doi. https:\/\/doi.org\/10.1038\/s41531-017-0013-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"5402_CR359","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13311-016-0449-z","volume":"13","author":"KE Olson","year":"2016","unstructured":"Olson KE, Bade AN, Schutt CR, Dong J, Shandler SJ, Boska MD et al (2016) Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 agonist therapy in a model of Parkinson\u2019s Disease. Neurotherapeutics 13(3):635\u2013646. https:\/\/doi.org\/10.1007\/s13311-016-0449-z","journal-title":"Neurotherapeutics"},{"key":"5402_CR360","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fncel.2019.00421","volume":"13","author":"RL Mosley","year":"2019","unstructured":"Mosley RL, Lu Y, Olson KE, Machhi J, Yan W, Namminga KL et al (2019) A synthetic agonist to Vasoactive Intestinal Peptide Receptor-2 induces Regulatory T Cell neuroprotective activities in models of Parkinson\u2019s Disease. Front Cell Neurosci 13:421. https:\/\/doi.org\/10.3389\/fncel.2019.00421","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"5402_CR361","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1164\/rccm.202301-0181OC","volume":"208","author":"CN Chen","year":"2023","unstructured":"Chen CN, Hajji N, Yeh FC, Rahman S, Ali S, Wharton J et al (2023) Restoration of Foxp3(+) Regulatory T cells by HDAC-Dependent epigenetic modulation plays a pivotal role in resolving pulmonary arterial hypertension Pathology. Am J Respir Crit Care Med 208(8):879\u2013895. https:\/\/doi.org\/10.1164\/rccm.202301-0181OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5402_CR362","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.4110\/in.2023.23.e37","volume":"23","author":"YS Jang","year":"2023","unstructured":"Jang YS, Park SH, Kang SG, Lee JS, Ko HJ, Kim PH (2023) Combined Treatment with TGF-beta1, retinoic acid, and Lactoferrin robustly generate Inducible Tregs (iTregs) Against High Affinity ligand. Immune Netw 23(5):e37. https:\/\/doi.org\/10.4110\/in.2023.23.e37","journal-title":"Immune Netw"},{"issue":"2","key":"5402_CR363","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","volume":"31","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE (2023) A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 31(2):673\u2013688. https:\/\/doi.org\/10.1007\/s10787-023-01192-2","journal-title":"Inflammopharmacology"},{"key":"5402_CR364","doi-asserted-by":"publisher","first-page":"154044","DOI":"10.1016\/j.phymed.2022.154044","volume":"100","author":"P Chen","year":"2022","unstructured":"Chen P, Zhang J, Wang C, Chai YH, Wu AG, Huang NY et al (2022) The pathogenesis and treatment mechanism of Parkinson\u2019s disease from the perspective of traditional Chinese medicine. Phytomedicine 100:154044. https:\/\/doi.org\/10.1016\/j.phymed.2022.154044","journal-title":"Phytomedicine"},{"issue":"8","key":"5402_CR365","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","volume":"42","author":"H Mirzaei","year":"2022","unstructured":"Mirzaei H, Sedighi S, Kouchaki E, Barati E, Dadgostar E, Aschner M et al (2022) Probiotics and the treatment of Parkinson\u2019s Disease: an update. Cell Mol Neurobiol 42(8):2449\u20132457. https:\/\/doi.org\/10.1007\/s10571-021-01128-w","journal-title":"Cell Mol Neurobiol"},{"key":"5402_CR366","doi-asserted-by":"publisher","unstructured":"Pignolo A, Mastrilli S, Davi C, Arnao V, Aridon P, Dos Santos Mendes FA et al (2022) Vitamin D and Parkinson\u2019s Disease. Nutrients 14(6). https:\/\/doi.org\/10.3390\/nu14061220","DOI":"10.3390\/nu14061220"},{"key":"5402_CR367","doi-asserted-by":"publisher","first-page":"880897","DOI":"10.3389\/fnagi.2022.880897","volume":"14","author":"R Ni","year":"2022","unstructured":"Ni R, Yuan Y, Yang L, Meng Q, Zhu Y, Zhong Y et al (2022) Novel non-invasive transcranial electrical stimulation for Parkinson\u2019s Disease. Front Aging Neurosci 14:880897. https:\/\/doi.org\/10.3389\/fnagi.2022.880897","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"5402_CR368","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1574888X18666230222144116","volume":"19","author":"A Nasrolahi","year":"2024","unstructured":"Nasrolahi A, Shabani Z, Sadigh-Eteghad S, Salehi-Pourmehr H, Mahmoudi J (2024) Stem cell therapy for the treatment of Parkinson\u2019s Disease: what Promise does it hold? Curr Stem Cell Res Ther 19(2):185\u2013199. https:\/\/doi.org\/10.2174\/1574888X18666230222144116","journal-title":"Curr Stem Cell Res Ther"},{"key":"5402_CR369","doi-asserted-by":"publisher","DOI":"10.2174\/0118715249283159240316091312","author":"F Hassanzadeh Kiabi","year":"2024","unstructured":"Hassanzadeh Kiabi F, Gharooee Ahangar S, Beiranvand S (2024) Assessing blood-brain barrier function in the context of Pain Management. Cent Nerv Syst Agents Med Chem. https:\/\/doi.org\/10.2174\/0118715249283159240316091312","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"5","key":"5402_CR370","doi-asserted-by":"publisher","first-page":"477","DOI":"10.22038\/IJBMS.2019.34011.8091","volume":"22","author":"E Ramazani","year":"2019","unstructured":"Ramazani E, Tayarani-Najaran Z, Fereidoni M (2019) Celecoxib, Indomethacin, and ibuprofen prevent 6-hydroxydopamine-induced PC12 cell death through the inhibition of NFkappaB and SAPK\/JNK pathways. Iran J Basic Med Sci 22(5):477\u2013484. https:\/\/doi.org\/10.22038\/IJBMS.2019.34011.8091","journal-title":"Iran J Basic Med Sci"},{"issue":"10","key":"5402_CR371","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/mds.28189","volume":"35","author":"M San Luciano","year":"2020","unstructured":"San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE et al (2020) Nonsteroidal anti-inflammatory use and LRRK2 Parkinson\u2019s Disease Penetrance. Mov Disord 35(10):1755\u20131764. https:\/\/doi.org\/10.1002\/mds.28189","journal-title":"Mov Disord"},{"issue":"1","key":"5402_CR372","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/can.2018.0051","volume":"4","author":"A Sabatucci","year":"2019","unstructured":"Sabatucci A, Simonetti M, Tortolani D, Angelucci CB, Dainese E, Maccarrone M (2019) Role of steroids on the membrane binding ability of fatty acid Amide Hydrolase. Cannabis Cannabinoid Res 4(1):42\u201350. https:\/\/doi.org\/10.1089\/can.2018.0051","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"5402_CR373","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/s0361-9230(03)00144-8","volume":"61","author":"HF Miranda","year":"2003","unstructured":"Miranda HF, Lemus I, Pinardi G (2003) Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Res Bull 61(4):417\u2013425. https:\/\/doi.org\/10.1016\/s0361-9230(03)00144-8","journal-title":"Brain Res Bull"},{"issue":"5","key":"5402_CR374","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3969\/j.issn.1673-5374.2012.05.001","volume":"7","author":"C Li","year":"2012","unstructured":"Li C, Chen X, Zhang N, Song Y, Mu Y (2012) Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson\u2019s disease model rats. Neural Regen Res 7(5):325\u2013331. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.05.001","journal-title":"Neural Regen Res"},{"key":"5402_CR375","doi-asserted-by":"publisher","first-page":"618787","DOI":"10.3389\/fphar.2020.618787","volume":"11","author":"S Huang","year":"2020","unstructured":"Huang S, Liu H, Lin Y, Liu M, Li Y, Mao H et al (2020) Berberine protects against NLRP3 inflammasome via ameliorating autophagic impairment in MPTP-Induced Parkinson\u2019s Disease Model. Front Pharmacol 11:618787. https:\/\/doi.org\/10.3389\/fphar.2020.618787","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"5402_CR376","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2011.05.006","volume":"310","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P (2011) The importance of non-motor disturbances to quality of life in Parkinson\u2019s disease. J Neurol Sci 310(1\u20132):12\u201316. https:\/\/doi.org\/10.1016\/j.jns.2011.05.006","journal-title":"J Neurol Sci"},{"issue":"2","key":"5402_CR377","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L et al (2011) Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol 57(2):117\u2013121","journal-title":"Minerva Gastroenterol Dietol"},{"key":"5402_CR378","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu D, Ancusa OE, Georgescu LA, Ionita I, Reisz D (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: is there hope? Clin Interv Aging 11:1601\u20131608. https:\/\/doi.org\/10.2147\/CIA.S106284","journal-title":"Clin Interv Aging"},{"key":"5402_CR379","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","volume":"10","author":"L Magistrelli","year":"2019","unstructured":"Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M et al (2019) Probiotics May have Beneficial effects in Parkinson\u2019s Disease: in vitro evidence. Front Immunol 10:969. https:\/\/doi.org\/10.3389\/fimmu.2019.00969","journal-title":"Front Immunol"},{"issue":"1","key":"5402_CR380","doi-asserted-by":"publisher","first-page":"e12877","DOI":"10.1016\/j.heliyon.2023.e12877","volume":"9","author":"W Wang","year":"2023","unstructured":"Wang W, Li Y, Meng X (2023) Vitamin D and neurodegenerative diseases. Heliyon 9(1):e12877. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e12877","journal-title":"Heliyon"},{"issue":"2","key":"5402_CR381","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11481-016-9720-7","volume":"12","author":"R Calvello","year":"2017","unstructured":"Calvello R, Cianciulli A, Nicolardi G, De Nuccio F, Giannotti L, Salvatore R et al (2017) Vitamin D treatment attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an animal model of Parkinson\u2019s Disease, shifting M1 to M2 microglia responses. J Neuroimmune Pharmacol 12(2):327\u2013339. https:\/\/doi.org\/10.1007\/s11481-016-9720-7","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"5402_CR382","doi-asserted-by":"publisher","first-page":"e202111853","DOI":"10.1002\/anie.202111853","volume":"61","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Ji W, Zhang S, Gao N, Xu T, Wang X et al (2022) Vitamin D inhibits the early aggregation of alpha-synuclein and modulates exocytosis revealed by Electrochemical measurements. Angew Chem Int Ed Engl 61(1):e202111853. https:\/\/doi.org\/10.1002\/anie.202111853","journal-title":"Angew Chem Int Ed Engl"},{"issue":"9","key":"5402_CR383","doi-asserted-by":"publisher","first-page":"e0203637","DOI":"10.1371\/journal.pone.0203637","volume":"13","author":"AL Hiller","year":"2018","unstructured":"Hiller AL, Murchison CF, Lobb BM, O\u2019Connor S, O\u2019Connor M, Quinn JF (2018) A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson\u2019s disease: does age matter? PLoS ONE 13(9):e0203637. https:\/\/doi.org\/10.1371\/journal.pone.0203637","journal-title":"PLoS ONE"},{"key":"5402_CR384","doi-asserted-by":"publisher","first-page":"110003","DOI":"10.1016\/j.neuropharm.2024.110003","volume":"256","author":"A Ricci","year":"2024","unstructured":"Ricci A, Rubino E, Serra GP, Wallen-Mackenzie A (2024) Concerning neuromodulation as treatment of neurological and neuropsychiatric disorder: insights gained from selective targeting of the subthalamic nucleus, para-subthalamic nucleus and zona incerta in rodents. Neuropharmacology 256:110003. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110003","journal-title":"Neuropharmacology"},{"key":"5402_CR385","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbi.2020.07.035","volume":"90","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhu G, Liu D, Zhang X, Liu Y, Yuan T et al (2020) Subthalamic nucleus deep brain stimulation suppresses neuroinflammation by Fractalkine pathway in Parkinson\u2019s disease rat model. Brain Behav Immun 90:16\u201325. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.035","journal-title":"Brain Behav Immun"},{"issue":"6","key":"5402_CR386","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-019-00784-3","volume":"40","author":"ACP Campos","year":"2020","unstructured":"Campos ACP, Kikuchi DS, Paschoa AFN, Kuroki MA, Fonoff ET, Hamani C et al (2020) Unraveling the role of astrocytes in Subthalamic Nucleus Deep Brain Stimulation in a Parkinson\u2019s Disease Rat Model. Cell Mol Neurobiol 40(6):939\u2013954. https:\/\/doi.org\/10.1007\/s10571-019-00784-3","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"5402_CR387","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/1673-5374.393104","volume":"20","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yuan T, Lyu T, Zhang L, Wang M, He Z et al (2025) Mechanism of inflammatory response and therapeutic effects of stem cells in ischemic stroke: current evidence and future perspectives. Neural Regen Res 20(1):67\u201381. https:\/\/doi.org\/10.4103\/1673-5374.393104","journal-title":"Neural Regen Res"},{"key":"5402_CR388","doi-asserted-by":"publisher","unstructured":"Gordon J, Lockard G, Monsour M, Alayli A, Choudhary H, Borlongan CV (2022) Sequestration of Inflammation in Parkinson\u2019s Disease via Stem Cell Therapy. Int J Mol Sci 23(17). https:\/\/doi.org\/10.3390\/ijms231710138","DOI":"10.3390\/ijms231710138"},{"issue":"9","key":"5402_CR389","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.4252\/wjsc.v13.i9.1215","volume":"13","author":"IK Kim","year":"2021","unstructured":"Kim IK, Park JH, Kim B, Hwang KC, Song BW (2021) Recent advances in stem cell therapy for neurodegenerative disease: three dimensional tracing and its emerging use. World J Stem Cells 13(9):1215\u20131230. https:\/\/doi.org\/10.4252\/wjsc.v13.i9.1215","journal-title":"World J Stem Cells"},{"issue":"5","key":"5402_CR390","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","volume":"15","author":"S Grealish","year":"2014","unstructured":"Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y et al (2014) Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease. Cell Stem Cell 15(5):653\u2013665. https:\/\/doi.org\/10.1016\/j.stem.2014.09.017","journal-title":"Cell Stem Cell"},{"issue":"7669","key":"5402_CR391","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, Morizane A, Doi D, Magotani H, Onoe H, Hayashi T et al (2017) Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature 548(7669):592\u2013596. https:\/\/doi.org\/10.1038\/nature23664","journal-title":"Nature"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05402-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05402-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05402-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T21:03:31Z","timestamp":1723928611000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05402-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":391,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5402"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05402-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"352"}}